Joseph Kamel Salama
Professor of Radiation Oncology
I have the privilege to be the Chief of the Durham VA Radiation Oncology Service, where I care for veterans who have served our country. I am a dedicated educator, serving as the Residency Program Director for the Duke Radiation Oncology Residency Program. I am also a cancer researcher developing novel treatment techniques for patients with head and neck cancer, lung cancer, prostate cancer, and those limited metastatic disease, and integration of these treatments with drug therapies.
Current Appointments & Affiliations
- Professor of Radiation Oncology, Radiation Oncology, Clinical Science Departments 2018
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2016
Contact Information
- 201 Trent Drive, Box 3085, Durham, NC 27710
- Box 3085, Duke University Medical Center, Durham, NC 27710
-
(919) 668-7339
- Background
-
Education, Training, & Certifications
- Chief Resident, Radiation Oncology, The University of Chicago 2005 - 2006
- Resident, Radiation Oncology, The University of Chicago 2002 - 2005
- Transitional Year Resident, Radiation Oncology, University of Texas Medical School, Houston 2001 - 2002
- M.D., Baylor College of Medicine 2001
-
Previous Appointments & Affiliations
- Associate Professor of Radiation Oncology, Radiation Oncology, Clinical Science Departments 2015 - 2018
- Associate Professor of Radiation Oncology, Radiation Oncology, Clinical Science Departments 2011 - 2015
- Assistant Professor of Radiation Oncology, Radiation Oncology, Clinical Science Departments 2010 - 2011
- Research
-
Selected Grants
-
External Relationships
- Alliance for Clinical Trials in Oncology
- American Society of Radiation Oncology
- Exact Sciences
- NRG Oncology
- UpToDate, Inc
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Carpenter, David J., Jim Leng, Muzamil Arshad, Will Giles, John P. Kirkpatrick, Scott R. Floyd, Steven J. Chmura, Joseph K. Salama, and Julian C. Hong. “Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases.” Jama Netw Open 6, no. 4 (April 3, 2023): e2310117. https://doi.org/10.1001/jamanetworkopen.2023.10117.Full Text Link to Item
-
Fairchild, Andrew T., Joseph K. Salama, Walter F. Wiggins, Bradley G. Ackerson, Peter E. Fecci, John P. Kirkpatrick, Scott R. Floyd, and Devon J. Godfrey. “A Deep Learning-Based Computer Aided Detection (CAD) System for Difficult-to-Detect Brain Metastases.” Int J Radiat Oncol Biol Phys 115, no. 3 (March 1, 2023): 779–93. https://doi.org/10.1016/j.ijrobp.2022.09.068.Full Text Link to Item
-
Carpenter, David J., Joseph K. Salama, W Robert Lee, and Matthew J. Boyer. “Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: a secondary analysis of RTOG 0415.” Prostate Cancer Prostatic Dis, February 27, 2023. https://doi.org/10.1038/s41391-023-00653-7.Full Text Link to Item
-
Janes, Jessica L., Matthew J. Boyer, John P. Bennett, Vanessa M. Thomas, Amanda M. De Hoedt, David K. Edwards V, Purva K. Singla, et al. “The 17-Gene Genomic Prostate Score Test Is Prognostic for Outcomes After Primary External Beam Radiation Therapy in Men With Clinically Localized Prostate Cancer.” Int J Radiat Oncol Biol Phys 115, no. 1 (January 1, 2023): 120–31. https://doi.org/10.1016/j.ijrobp.2022.06.101.Full Text Link to Item
-
Carpenter, David J., Brahma Natarajan, Muzamil Arshad, Divya Natesan, Olivia Schultz, Michael J. Moravan, Charlotte Read, et al. “Prognostic Model for Intracranial Progression after Stereotactic Radiosurgery: A Multicenter Validation Study.” Cancers (Basel) 14, no. 21 (October 22, 2022). https://doi.org/10.3390/cancers14215186.Full Text Link to Item
-
Owen, Dawn, Shankar Siva, Joseph K. Salama, Clifford Robinson, Timothy J. Kruser, and Meredith Giuliani. “If at First You Don't Succeed-Stereotactic Body Radiation Therapy for Recurrent Non-Small Cell Lung Cancer.” Int J Radiat Oncol Biol Phys 114, no. 1 (September 1, 2022): 5–9. https://doi.org/10.1016/j.ijrobp.2022.04.010.Full Text Link to Item
-
Carpenter, David J., Divya Natesan, R Warren Floyd, Taofik Oyekunle, Donna Niedzwiecki, Laura Waters, Devon Godfrey, et al. “Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access Setting.” Fed Pract 39, no. Suppl 3 (August 2022): S35–41. https://doi.org/10.12788/fp.0305.Full Text Link to Item
-
Brownstein, Jeremy, and Joseph K. Salama. “Moderately Hypofractionated Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: A New Way Forward for Dose Escalation?” Int J Radiat Oncol Biol Phys 113, no. 4 (July 15, 2022): 749–51. https://doi.org/10.1016/j.ijrobp.2022.04.023.Full Text Link to Item
-
Schild, Steven E., Xiaofei Wang, Christine M. Bestvina, Terence Williams, Greg Masters, Anurag K. Singh, Thomas E. Stinchcombe, et al. “Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer.” Clin Lung Cancer 23, no. 5 (July 2022): e317–20. https://doi.org/10.1016/j.cllc.2022.04.004.Full Text Link to Item
-
Shenker, Rachel F., Jeremy G. Price, Corbin D. Jacobs, Manisha Palta, Brian G. Czito, Yvonne M. Mowery, John P. Kirkpatrick, et al. “Comparing Outcomes of Oligometastases Treated with Hypofractionated Image-Guided Radiotherapy (HIGRT) with a Simultaneous Integrated Boost (SIB) Technique versus Metastasis Alone: A Multi-Institutional Analysis.” Cancers (Basel) 14, no. 10 (May 13, 2022). https://doi.org/10.3390/cancers14102403.Full Text Link to Item
-
Robinson, Clifford, Timothy J. Kruser, Dawn Owen, Joseph Salama, and Megan E. Daly. “Fast and Furious: New Data Examining Accelerated Radiation Therapy for Limited-Stage Small Cell Lung Cancer.” Int J Radiat Oncol Biol Phys 112, no. 5 (April 1, 2022): 1067–70. https://doi.org/10.1016/j.ijrobp.2021.12.151.Full Text Link to Item
-
Mowery, Yvonne M., and Joseph K. Salama. “Interpreting ORATOR: Lessons Learned From a Randomized Comparison of Primary Surgical and Radiation Approaches for Early-Stage Oropharyngeal Cancer.” J Clin Oncol 40, no. 8 (March 10, 2022): 814–17. https://doi.org/10.1200/JCO.21.02813.Full Text Link to Item
-
Jacobs, Corbin D., Kurren Mehta, Junheng Gao, Xiaofei Wang, Joseph K. Salama, Chris R. Kelsey, and Jordan A. Torok. “Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.” Clin Lung Cancer 23, no. 2 (March 2022): 177–84. https://doi.org/10.1016/j.cllc.2021.06.008.Full Text Link to Item
-
Milano, Michael T., Joseph K. Salama, and Steven J. Chmura. “Should We Target Oligometastatic EGFR-Mutated NSCLC with Radiotherapy before Administering Targeted Systemic Therapy?” J Natl Cancer Inst, January 30, 2022. https://doi.org/10.1093/jnci/djac016.Full Text Link to Item
-
Natesan, Divya, David J. Carpenter, Warren Floyd, Taofik Oyekunle, Donna Niedzwiecki, Laura Waters, Devon Godfrey, Michael J. Moravan, William Robert Lee, and Joseph K. Salama. “Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer.” Adv Radiat Oncol 7, no. 2 (2022): 100805. https://doi.org/10.1016/j.adro.2021.100805.Full Text Link to Item
-
Kozono, David E., Thomas E. Stinchcombe, Joseph K. Salama, Jeffrey Bogart, W Jeffrey Petty, Michael J. Guarino, Lyudmila Bazhenova, et al. “Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer.” Lung Cancer 159 (September 2021): 56–65. https://doi.org/10.1016/j.lungcan.2021.06.028.Full Text Link to Item
-
Vapiwala, Neha, J Karen Wong, Elizabeth Handorf, Jonathan Paly, Amardeep Grewal, Rahul Tendulkar, Devon Godfrey, et al. “A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients.” Int J Radiat Oncol Biol Phys 110, no. 4 (July 15, 2021): 1082–89. https://doi.org/10.1016/j.ijrobp.2021.01.043.Full Text Link to Item
-
Chmura, Steve, Kathryn A. Winter, Clifford Robinson, Thomas M. Pisansky, Virginia Borges, Hania Al-Hallaq, Martha Matuszak, et al. “Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial.” Jama Oncol 7, no. 6 (June 1, 2021): 845–52. https://doi.org/10.1001/jamaoncol.2021.0687.Full Text Link to Item
-
Kruser, Tim J., Clifford Robinson, Dawn Owen, Joseph K. Salama, and Megan E. Daly. “Strike or Spare? A Review of Lung-Sparing Therapies for Malignant Pleural Mesothelioma.” Int J Radiat Oncol Biol Phys 110, no. 2 (June 1, 2021): 257–60. https://doi.org/10.1016/j.ijrobp.2021.02.016.Full Text Link to Item
-
Salama, Joseph K., Scott R. Floyd, Christopher G. Willett, and David G. Kirsch. “Fostering Radiation Oncology Physician Scientist Trainees Within a Diverse Workforce: The Radiation Oncology Research Scholar Track.” Int J Radiat Oncol Biol Phys 110, no. 2 (June 1, 2021): 288–91. https://doi.org/10.1016/j.ijrobp.2020.12.050.Full Text Open Access Copy Link to Item
-
Sands, Jacob M., Sumithra J. Mandrekar, David Kozono, Geoffrey R. Oxnard, Shauna L. Hillman, Dennis A. Wigle, Ramaswamy Govindan, et al. “Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO).” Immunotherapy 13, no. 9 (June 2021): 727–34. https://doi.org/10.2217/imt-2021-0019.Full Text Link to Item
-
Kent, Collin L., Susan G. R. McDuff, and Joseph K. Salama. “Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.” Ann Palliat Med 10, no. 5 (May 2021): 5954–68. https://doi.org/10.21037/apm-20-1128.Full Text Link to Item
-
Salama, Joseph K., Meredith E. Giuliani, Clifford G. Robinson, and Megan E. Daly. “Single-fraction SBRT for Early Stage NSCLC-A Viable Option in "These Uncertain Times"?” Int J Radiat Oncol Biol Phys 109, no. 1 (January 1, 2021): 1–4. https://doi.org/10.1016/j.ijrobp.2020.08.031.Full Text Link to Item
-
Chodavadia, Parth A., Corbin D. Jacobs, Frances Wang, Joseph K. Salama, Chris R. Kelsey, Jeffrey M. Clarke, Neal E. Ready, and Jordan A. Torok. “Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer.” Transl Lung Cancer Res 10, no. 1 (January 2021): 261–73. https://doi.org/10.21037/tlcr-20-537.Full Text Link to Item
-
Godfrey, Devon J., Sarah Jo Stephens, Daniele Marin, Michael J. Moravan, Joseph K. Salama, and Manisha Palta. “Seeing is believing: A roadmap for implementing bolus-tracked multiphasic CT simulation for ablative radiotherapy of abdominal malignancies.” J Radiosurg Sbrt 7, no. 3 (2021): 253–55.Link to Item
-
Price, Jeremy G., Donna Niedzwiecki, Taofik Oyekunle, Murat O. Arcasoy, Colin E. Champ, Chris R. Kelsey, Joseph K. Salama, and Michael J. Moravan. “Effective Pain Control With Very Low Dose Palliative Radiation Therapy for Patients With Multiple Myeloma With Uncomplicated Osseous Lesions.” Adv Radiat Oncol 6, no. 4 (2021): 100729. https://doi.org/10.1016/j.adro.2021.100729.Full Text Link to Item
-
Price, Jeremy G., Michael J. Moravan, Matthew J. Boyer, Manisha Palta, Sarah Jo Stephens, Christine E. Eyler, Joshua J. Siglin, et al. “Facilitating the Transition to Independent Radiation Oncology Practice Through a Resident-Led, Veterans Affairs Teaching Hospital Service.” Pract Radiat Oncol 11, no. 6 (2021): 441–47. https://doi.org/10.1016/j.prro.2021.08.006.Full Text Link to Item
-
Luke, Jason J., Benjamin E. Onderdonk, Sandeep R. Bhave, Theodore Karrison, Jeffrey M. Lemons, Paul Chang, Yuanyuan Zha, et al. “Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 26, no. 24 (December 2020): 6437–44. https://doi.org/10.1158/1078-0432.ccr-20-1790.Full Text
-
Price, Jeremy G., Daphna Y. Spiegel, David S. Yoo, Michael J. Moravan, Yvonne M. Mowery, Donna Niedzwiecki, David M. Brizel, and Joseph K. Salama. “Development and Implementation of an Educational Simulation Workshop in Fiberoptic Laryngoscopy for Radiation Oncology Residents.” Int J Radiat Oncol Biol Phys 108, no. 3 (November 1, 2020): 615–19. https://doi.org/10.1016/j.ijrobp.2020.05.009.Full Text Link to Item
-
Di Bella, Claire M., Lauren E. Howard, Taofik Oyekunle, Amanda M. De Hoedt, Joseph K. Salama, Haijun Song, Stephen J. Freedland, and Emma H. Allott. “Abdominal and pelvic adipose tissue distribution and risk of prostate cancer recurrence after radiation therapy.” Prostate 80, no. 14 (October 2020): 1244–52. https://doi.org/10.1002/pros.24054.Full Text Link to Item
-
Moravan, Michael J., Peter E. Fecci, Carey K. Anders, Jeffrey M. Clarke, April K. S. Salama, Justus D. Adamson, Scott R. Floyd, et al. “Current multidisciplinary management of brain metastases.” Cancer 126, no. 7 (April 1, 2020): 1390–1406. https://doi.org/10.1002/cncr.32714.Full Text Link to Item
-
Giuliani, Meredith E., Clifford G. Robinson, Joseph K. Salama, and Megan E. Daly. “Oligoreview of Non-Small Cell Lung Cancer Oligometastases.” Int J Radiat Oncol Biol Phys 106, no. 3 (March 1, 2020): 455–59. https://doi.org/10.1016/j.ijrobp.2019.11.009.Full Text Link to Item
-
Spiegel, Daphna Y., Matthew J. Boyer, Julian C. Hong, Christina D. Williams, Michael J. Kelley, Joseph K. Salama, and Manisha Palta. “Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis.” J Natl Compr Canc Netw 18, no. 1 (January 2020): 52–58. https://doi.org/10.6004/jnccn.2019.7329.Full Text Link to Item
-
Milano, Michael T., Amit K. Chowdhry, Joseph K. Salama, and Steven J. Chmura. “Signals from SABR-COMET time to move on to phase III studies.” Ann Transl Med 7, no. Suppl 8 (December 2019): S316. https://doi.org/10.21037/atm.2019.09.152.Full Text Link to Item
-
Vernuccio, Federica, Devon Godfrey, Mathias Meyer, Hannah V. Williamson, Joseph K. Salama, Donna Niedzwiecki, Sarah Jo Stephens, James Ronald, Manisha Palta, and Daniele Marin. “Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria.” Ajr Am J Roentgenol 213, no. 6 (December 2019): 1232–39. https://doi.org/10.2214/AJR.18.20842.Full Text Link to Item
-
Torok, Jordan A., and Joseph K. Salama. “Combining immunotherapy and radiotherapy for the STAR treatment.” Nat Rev Clin Oncol 16, no. 11 (November 2019): 666–67. https://doi.org/10.1038/s41571-019-0277-2.Full Text Link to Item
-
Tay, Kae Jack, Thomas J. Polascik, Lauren E. Howard, Joseph K. Salama, Ariel A. Schulman, Zinan Chen, Christopher L. Amling, et al. “Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?” Clin Genitourin Cancer 17, no. 5 (October 2019): e930–38. https://doi.org/10.1016/j.clgc.2019.05.007.Full Text Link to Item
-
Natarajan, Brahma D., Corbin D. Jacobs, and Joseph K. Salama. “Radiotherapy and Small Cell Carcinoma With Paraneoplastic Polyneuropathy: A Case Report.” Ann Intern Med 171, no. 6 (September 17, 2019): 440–41. https://doi.org/10.7326/L19-0236.Full Text Link to Item
-
Mowery, Yvonne M., Kirtesh Patel, Mudit Chowdhary, Christel N. Rushing, Kingshuk Roy Choudhury, Jared R. Lowe, Adam C. Olson, et al. “Retrospective analysis of safety and efficacy of anti-PD-1 therapy and radiation therapy in advanced melanoma: A bi-institutional study.” Radiother Oncol 138 (September 2019): 114–20. https://doi.org/10.1016/j.radonc.2019.06.013.Full Text Link to Item
-
Hong, Julian C., and Joseph K. Salama. “Authors' Reply.” J Natl Compr Canc Netw 17, no. 8 (August 1, 2019): xxxixa-xl. https://doi.org/10.6004/jnccn.2019.7338.Full Text Link to Item
-
Spiegel, Daphna Y., Julian C. Hong, Taofik Oyekunle, Laura Waters, W Robert Lee, Joseph K. Salama, and Bridget F. Koontz. “A Nomogram for Testosterone Recovery After Combined Androgen Deprivation and Radiation Therapy for Prostate Cancer.” Int J Radiat Oncol Biol Phys 103, no. 4 (March 15, 2019): 834–42. https://doi.org/10.1016/j.ijrobp.2018.11.007.Full Text Link to Item
-
Spiegel, Daphna Y., Matthew J. Boyer, Julian C. Hong, Christina D. Williams, Michael J. Kelley, Harvey Moore, Joseph K. Salama, and Manisha Palta. “Long-term Clinical Outcomes of Nonoperative Management With Chemoradiotherapy for Locally Advanced Rectal Cancer in the Veterans Health Administration.” Int J Radiat Oncol Biol Phys 103, no. 3 (March 1, 2019): 565–73. https://doi.org/10.1016/j.ijrobp.2018.10.018.Full Text Link to Item
-
Hong, Julian C., Matthew J. Boyer, Daphna Y. Spiegel, Christina D. Williams, Betty C. Tong, Scott L. Shofer, Michael J. Moravan, Michael J. Kelley, and Joseph K. Salama. “Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry.” J Natl Compr Canc Netw 17, no. 2 (February 2019): 127–39. https://doi.org/10.6004/jnccn.2018.7090.Full Text Link to Item
-
Abisheva, Zhanerke, Scott R. Floyd, Joseph K. Salama, John Kirkpatrick, Fang-Fang Yin, Michael J. Moravan, William Giles, and Justus Adamson. “The effect of MLC leaf width in single-isocenter multi-target radiosurgery with volumetric modulated arc therapy.” J Radiosurg Sbrt 6, no. 2 (2019): 131–38.Open Access Copy Link to Item
-
Jacobs, Corbin D., Manisha Palta, Hannah Williamson, Jeremy G. Price, Brian G. Czito, Joseph K. Salama, and Michael J. Moravan. “Hypofractionated Image-Guided Radiation Therapy With Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis.” Front Oncol 9 (2019): 469. https://doi.org/10.3389/fonc.2019.00469.Full Text Open Access Copy Link to Item
-
Natarajan, Brahma D., Christel N. Rushing, Michael A. Cummings, Jessica Ms Jutzy, Kingshuk R. Choudhury, Michael J. Moravan, Peter E. Fecci, et al. “Predicting intracranial progression following stereotactic radiosurgery for brain metastases: Implications for post SRS imaging.” J Radiosurg Sbrt 6, no. 3 (2019): 179–87.Link to Item
-
Palta, Manisha, Devon Godfrey, Karyn A. Goodman, Sarah Hoffe, Laura A. Dawson, David Dessert, William A. Hall, et al. “Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.” Pract Radiat Oncol 9, no. 5 (2019): 322–32. https://doi.org/10.1016/j.prro.2019.06.016.Full Text Link to Item
-
Song, Haijun, Joseph K. Salama, William Robert Lee, and Qiuwen Wu. “Nonuniform Planning Target Volume Margins for Prostate Bed on the Basis of Surgical Clips on Daily Cone Beam Computed Tomography.” Adv Radiat Oncol 4, no. 1 (2019): 186–90. https://doi.org/10.1016/j.adro.2018.09.014.Full Text Open Access Copy Link to Item
-
Zhang, Jiang, Q Jackie Wu, Yaorong Ge, Chunhao Wang, Yang Sheng, Jatinder Palta, Joseph K. Salama, Fang-Fang Yin, and Jiahan Zhang. “Knowledge-Based Statistical Inference Method for Plan Quality Quantification.” Technol Cancer Res Treat 18 (January 1, 2019): 1533033819857758. https://doi.org/10.1177/1533033819857758.Full Text Open Access Copy Link to Item
-
Chino, Fumiko, Kimberly Ellen Pollis, Steve Choi, Joseph K. Salama, and Manisha Palta. “Stereotactic Body Radiation Therapy-Induced Abscopal Effect on Hepatocellular Carcinoma After Treatment for Lung Cancer: A Case Report.” Hepatology 68, no. 4 (October 2018): 1653–55. https://doi.org/10.1002/hep.30100.Full Text Link to Item
-
Tandberg, Daniel J., Taofik Oyekunle, W Robert Lee, Yuan Wu, Joseph K. Salama, and Bridget F. Koontz. “Postoperative Radiation Therapy for Prostate Cancer: Comparison of Conventional Versus Hypofractionated Radiation Regimens.” Int J Radiat Oncol Biol Phys 101, no. 2 (June 1, 2018): 396–405. https://doi.org/10.1016/j.ijrobp.2018.02.002.Full Text Link to Item
-
Hong, Julian C., Diandra N. Ayala-Peacock, Jason Lee, A William Blackstock, Paul Okunieff, Max W. Sung, Ralph R. Weichselbaum, et al. “Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.” Plos One 13, no. 4 (2018): e0195149. https://doi.org/10.1371/journal.pone.0195149.Full Text Link to Item
-
Stephens, Sarah Jo, Michael J. Moravan, and Joseph K. Salama. “Managing Patients With Oligometastatic Non-Small-Cell Lung Cancer.” J Oncol Pract 14, no. 1 (January 2018): 23–31. https://doi.org/10.1200/JOP.2017.026500.Full Text Link to Item
-
Boyer, Matthew J., Christina D. Williams, David H. Harpole, Mark W. Onaitis, Michael J. Kelley, and Joseph K. Salama. “Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.” J Thorac Oncol 12, no. 12 (December 2017): 1814–23. https://doi.org/10.1016/j.jtho.2017.09.1952.Full Text Link to Item
-
Moravan, Michael J., and Joseph K. Salama. “Metastasis-Directed Therapy: Right for Some, but Not All, and Not Here.” Int J Radiat Oncol Biol Phys 99, no. 4 (November 15, 2017): 767. https://doi.org/10.1016/j.ijrobp.2017.03.047.Full Text Link to Item
-
Lewis, Stephen L., Sandro Porceddu, Naoki Nakamura, David A. Palma, Simon S. Lo, Peter Hoskin, Drew Moghanaki, Steven J. Chmura, and Joseph K. Salama. “Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists.” Am J Clin Oncol 40, no. 4 (August 2017): 418–22. https://doi.org/10.1097/COC.0000000000000169.Full Text Link to Item
-
Mowery, Yvonne M., Joseph K. Salama, S Yousuf Zafar, Harvey G. Moore, Christopher G. Willett, Brian G. Czito, M Benjamin Hopkins, and Manisha Palta. “Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.” Cancer 123, no. 8 (April 15, 2017): 1434–41. https://doi.org/10.1002/cncr.30461.Full Text Link to Item
-
Siddiqui, Farzan, Richard V. Smith, Sue S. Yom, Jonathan J. Beitler, Paul M. Busse, Jay S. Cooper, Ehab Y. Hanna, et al. “ACR appropriateness criteria® nasal cavity and paranasal sinus cancers.” Head Neck 39, no. 3 (March 2017): 407–18. https://doi.org/10.1002/hed.24639.Full Text Link to Item
-
Al-Hallaq, Hania A., Steven J. Chmura, Joseph K. Salama, Jessica R. Lowenstein, Susan McNulty, James M. Galvin, David S. Followill, et al. “Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.” Int J Radiat Oncol Biol Phys 97, no. 1 (January 1, 2017): 155–63. https://doi.org/10.1016/j.ijrobp.2016.09.030.Full Text Link to Item
-
Bergsma, Derek P., Joseph K. Salama, Deepinder P. Singh, Steven J. Chmura, and Michael T. Milano. “Radiotherapy for Oligometastatic Lung Cancer.” Front Oncol 7 (2017): 210. https://doi.org/10.3389/fonc.2017.00210.Full Text Link to Item
-
Godfrey, Devon J., Bhavik N. Patel, Justus D. Adamson, Ergys Subashi, Joseph K. Salama, and Manisha Palta. “Triphasic contrast enhanced CT simulation with bolus tracking for pancreas SBRT target delineation.” Pract Radiat Oncol 7, no. 6 (2017): e489–97. https://doi.org/10.1016/j.prro.2017.04.008.Full Text Link to Item
-
Hong, Julian C., and Joseph K. Salama. “The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?” Cancer Treat Rev 52 (January 2017): 22–32. https://doi.org/10.1016/j.ctrv.2016.11.003.Full Text Link to Item
-
Torok, Jordan A., Lin Gu, Daniel J. Tandberg, Xiaofei Wang, David H. Harpole, Chris R. Kelsey, and Joseph K. Salama. “Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer.” Clin Lung Cancer 18, no. 1 (January 2017): e57–70. https://doi.org/10.1016/j.cllc.2016.06.011.Full Text Link to Item
-
Birer, S. R., A. C. Olson, J. Adamson, G. J. Kim, J. K. Salama, and J. P. Kirkpatrick. “Hippocampal Dose From Stereotactic Radiosurgery for 4 to 10 Brain Metastases: Risk Factors and Feasibility of Dose Reduction Via Reoptimization.” Int J Radiat Oncol Biol Phys 96, no. 2S (October 1, 2016): E608–9. https://doi.org/10.1016/j.ijrobp.2016.06.2153.Full Text Link to Item
-
Boyer, M. J., C. Williams, M. J. Kelley, and J. K. Salama. “Survival With Stereotactic Body Radiation Therapy (SBRT) and Conventional Radiation Therapy (CRT) in Stage I Non-Small Cell Lung Cancer Patients in the Veterans Affairs System.” Int J Radiat Oncol Biol Phys 96, no. 2S (October 1, 2016): S9. https://doi.org/10.1016/j.ijrobp.2016.06.037.Full Text Link to Item
-
Godfrey, D. J., B. N. Patel, J. Adamson, J. K. Salama, and M. Palta. “Triphasic Bolus Tracking Computed Tomography Simulation for Stereotactic Body Radiation Therapy of Locoregionally Advanced Pancreatic Cancer.” Int J Radiat Oncol Biol Phys 96, no. 2S (October 1, 2016): E200–201. https://doi.org/10.1016/j.ijrobp.2016.06.1095.Full Text Link to Item
-
Lemons, J. M., S. J. Chmura, J. J. Luke, J. K. Salama, and H. A. Al-Hallaq. “Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors.” Int J Radiat Oncol Biol Phys 96, no. 2S (October 1, 2016): E631–32. https://doi.org/10.1016/j.ijrobp.2016.06.2209.Full Text Link to Item
-
Mowery, Y. M., J. K. Salama, S. Y. Zafar, H. G. Moore, C. G. Willett, B. Czito, M. B. Hopkins, and M. Palta. “Radiation Oncologists' Practice Patterns and Attitudes Regarding Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer in the United States.” Int J Radiat Oncol Biol Phys 96, no. 2S (October 1, 2016): S203. https://doi.org/10.1016/j.ijrobp.2016.06.505.Full Text Link to Item
-
Mowery, Y. M., K. Patel, A. C. Olson, M. K. Khan, J. K. Salama, and A. K. Salama. “Toxicity and Survival for Metastatic Melanoma Patients Treated With Anti-PD1 Therapy and Radiation Treatment.” Int J Radiat Oncol Biol Phys 96, no. 2S (October 1, 2016): S158–59. https://doi.org/10.1016/j.ijrobp.2016.06.383.Full Text Link to Item
-
Susko, M., J. Lee, J. K. Salama, S. Thomas, H. Uronis, D. Hsu, J. Migaly, C. G. Willett, B. Czito, and M. Palta. “The Use of Reirradiation in Locally Recurrent, Nonmetastatic Rectal Cancer.” Int J Radiat Oncol Biol Phys 96, no. 2S (October 1, 2016): E192–93. https://doi.org/10.1016/j.ijrobp.2016.06.1076.Full Text Link to Item
-
Hu, Fangyao, Karthik Vishwanath, Joseph K. Salama, Alaattin Erkanli, Bercedis Peterson, James R. Oleson, Walter T. Lee, David M. Brizel, Nimmi Ramanujam, and Mark W. Dewhirst. “Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.” Int J Radiat Oncol Biol Phys 96, no. 2 (October 1, 2016): 462–69. https://doi.org/10.1016/j.ijrobp.2016.06.007.Full Text Link to Item
-
Susko, Matthew, Jason Lee, Joseph Salama, Samantha Thomas, Hope Uronis, David Hsu, John Migaly, Christopher Willett, Brian Czito, and Manisha Palta. “The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer.” Ann Surg Oncol 23, no. 11 (October 2016): 3609–15. https://doi.org/10.1245/s10434-016-5250-z.Full Text Link to Item
-
Williams, Christina D., Joseph K. Salama, Drew Moghanaki, Tomer Z. Karas, and Michael J. Kelley. “Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer.” J Thorac Oncol 11, no. 10 (October 2016): 1672–81. https://doi.org/10.1016/j.jtho.2016.05.030.Full Text Link to Item
-
Qin, Rosie, Adam Olson, Bhavana Singh, Samantha Thomas, Steven Wolf, Nrupen A. Bhavsar, Brent A. Hanks, Joseph K. Salama, and April K. S. Salama. “Safety and Efficacy of Radiation Therapy in Advanced Melanoma Patients Treated With Ipilimumab.” Int J Radiat Oncol Biol Phys 96, no. 1 (September 1, 2016): 72–77. https://doi.org/10.1016/j.ijrobp.2016.04.017.Full Text Link to Item
-
Beitler, Jonathan J., Harry Quon, Christopher U. Jones, Joseph K. Salama, Paul M. Busse, Jay S. Cooper, Shlomo A. Koyfman, et al. “ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.” Head Neck 38, no. 9 (September 2016): 1299–1309. https://doi.org/10.1002/hed.24447.Full Text Link to Item
-
Olson, Adam C., Samantha Thomas, Rosie Qin, Bhavana Singh, Joseph K. Salama, John Kirkpatrick, and April Ks Salama. “Outcomes and toxicity of stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab.” Melanoma Manag 3, no. 3 (September 2016): 177–86. https://doi.org/10.2217/mmt-2016-0004.Full Text Link to Item
-
Seiwert, Tanguy Y., James M. Melotek, Elizabeth A. Blair, Kerstin M. Stenson, Joseph K. Salama, Mary Ellyn Witt, Ryan J. Brisson, et al. “Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.” Int J Radiat Oncol Biol Phys 96, no. 1 (September 1, 2016): 21–29. https://doi.org/10.1016/j.ijrobp.2016.04.030.Full Text Link to Item
-
Lee, Caroline M., Jason D. Lee, Lisa D. Hobson-Webb, Richard S. Bedlack, and Joseph K. Salama. “Treatment of Thymoma-Associated Myasthenia Gravis With Stereotactic Body Radiotherapy: A Case Report.” Ann Intern Med 165, no. 4 (August 16, 2016): 300–301. https://doi.org/10.7326/L15-0469.Full Text Link to Item
-
Mowery, Yvonne M., and Joseph K. Salama. “A Multidisciplinary Approach to Larynx Cancer: One Size Does Not Fit All.” J Oncol Pract 12, no. 8 (August 2016): 725–26. https://doi.org/10.1200/JOP.2016.014803.Full Text Link to Item
-
Boyer, Matthew J., Lin Gu, Xiaofei Wang, Chris R. Kelsey, David S. Yoo, Mark W. Onaitis, Frank R. Dunphy, Jeffrey Crawford, Neal E. Ready, and Joseph K. Salama. “Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer.” Lung Cancer 98 (August 2016): 76–78. https://doi.org/10.1016/j.lungcan.2016.05.014.Full Text Link to Item
-
Wong, Anthony C., Sydeaka P. Watson, Sean P. Pitroda, Christina H. Son, Lauren C. Das, Melinda E. Stack, Abhineet Uppal, et al. “Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT).” Cancer 122, no. 14 (July 15, 2016): 2242–50. https://doi.org/10.1002/cncr.30058.Full Text Link to Item
-
Onaitis, Mark W., and Joseph Salama. “Surgery versus stereotactic body radiation therapy for operable stage I non-small cell lung cancer: Can we achieve equipoise?” J Thorac Cardiovasc Surg 152, no. 1 (July 2016): 1–2. https://doi.org/10.1016/j.jtcvs.2016.04.016.Full Text Link to Item
-
Saba, Nabil F., Joseph K. Salama, Jonathan J. Beitler, Paul M. Busse, Jay S. Cooper, Christopher U. Jones, Shlomo Koyfman, et al. “ACR Appropriateness criteria® for nasopharyngeal carcinoma.” Head Neck 38, no. 7 (July 2016): 979–86. https://doi.org/10.1002/hed.24423.Full Text Link to Item
-
Drazer, Michael W., Joseph K. Salama, Olwen M. Hahn, Ralph R. Weichselbaum, and Steven J. Chmura. “Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?” Expert Rev Anticancer Ther 16, no. 6 (June 2016): 625–32. https://doi.org/10.1080/14737140.2016.1178577.Full Text Link to Item
-
Salama, April K. S., Michael A. Postow, and Joseph K. Salama. “Irradiation and immunotherapy: From concept to the clinic.” Cancer 122, no. 11 (June 1, 2016): 1659–71. https://doi.org/10.1002/cncr.29889.Full Text Link to Item
-
Lewis, Stephen L., Pretesh R. Patel, Manisha Palta, David S. Yoo, and Joseph K. Salama. “In Reply to Fiorino and Cozzarini.” Int J Radiat Oncol Biol Phys 94, no. 4 (March 15, 2016): 860–61. https://doi.org/10.1016/j.ijrobp.2016.01.009.Full Text Link to Item
-
Lewis, Stephen L., Pretesh Patel, Haijun Song, Stephen J. Freedland, Sigrun Bynum, Daniel Oh, Manisha Palta, David Yoo, James Oleson, and Joseph K. Salama. “Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.” Int J Radiat Oncol Biol Phys 94, no. 3 (March 1, 2016): 605–11. https://doi.org/10.1016/j.ijrobp.2015.11.025.Full Text Link to Item
-
Salama, Joseph K., Lin Gu, Xiaofei Wang, Herbert H. Pang, Jeffrey A. Bogart, Jeffrey Crawford, Steven E. Schild, Everett E. Vokes, and Neal E. Ready. “Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).” J Thorac Oncol 11, no. 3 (March 2016): 361–69. https://doi.org/10.1016/j.jtho.2015.11.001.Full Text Link to Item
-
Hong, Julian C., and Joseph K. Salama. “Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?” Transl Lung Cancer Res 5, no. 1 (February 2016): 126–33. https://doi.org/10.3978/j.issn.2218-6751.2016.01.07.Full Text Link to Item
-
Boyer, Matthew J., Umberto Ricardi, David Ball, and Joseph K. Salama. “Ablative Approaches for Pulmonary Metastases.” Thorac Surg Clin 26, no. 1 (February 2016): 19–34. https://doi.org/10.1016/j.thorsurg.2015.09.004.Full Text Link to Item
-
Koyfman, Shlomo A., Jay S. Cooper, Jonathan J. Beitler, Paul M. Busse, Christopher U. Jones, Mark W. McDonald, Harry Quon, et al. “ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.” Head Neck 38, no. 2 (February 2016): 175–82. https://doi.org/10.1002/hed.24171.Full Text Link to Item
-
Al-Hallaq, Hania A., Steven Chmura, Joseph K. Salama, Kathryn A. Winter, Clifford G. Robinson, Thomas M. Pisansky, Virginia Borges, et al. “Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.” Pract Radiat Oncol 6, no. 6 (2016): e291–98. https://doi.org/10.1016/j.prro.2016.05.004.Full Text Link to Item
-
Correa, Rohann J. M., Joseph K. Salama, Michael T. Milano, and David A. Palma. “Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management.” Cancer J 22, no. 4 (2016): 247–56. https://doi.org/10.1097/PPO.0000000000000202.Full Text Link to Item
-
Salama, Joseph K., Christina D. Williams, Drew Moghanaki, and Michael J. Kelley. “Improved Survival in Patients with Stage I-II NSCLC Treated with Surgery or Radiotherapy in the Department of Veterans Affairs.” Journal of Thoracic Oncology 10, no. 9 (September 1, 2015): S280–81.Link to Item
-
Salama, Joseph K., Lin Gu, Xiaofei Wang, Jeffrey Bogart, Jeffrey Crawford, Steven Schild, Neal Ready, and Everett Vokes. “PCI Survival Improvement for Extensive Stage SCLC Limited to Patients on Maintenance Systemic Therapy: A Secondary Analysis of CALGB 30504.” Journal of Thoracic Oncology 10, no. 9 (September 1, 2015): S401–S401.Link to Item
-
Salama, Joseph K., and Steven E. Schild. “Radiation therapy for oligometastatic non-small cell lung cancer.” Cancer Metastasis Rev 34, no. 2 (June 2015): 183–93. https://doi.org/10.1007/s10555-015-9559-z.Full Text Link to Item
-
Rule, William G., Nathan R. Foster, Jeffrey P. Meyers, Jonathan B. Ashman, Sujay A. Vora, Timothy F. Kozelsky, Yolanda I. Garces, James J. Urbanic, Joseph K. Salama, and Steven E. Schild. “Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis.” J Geriatr Oncol 6, no. 2 (March 2015): 119–26. https://doi.org/10.1016/j.jgo.2014.11.002.Full Text Link to Item
-
Simon, Ross M., Joseph K. Salama, and Stephen J. Freedland. “Radical prostatectomy versus radiation therapy: can pretreatment nomograms be used to select the appropriate prostate cancer treatment?” Eur Urol 67, no. 2 (February 2015): 210–11. https://doi.org/10.1016/j.eururo.2014.10.009.Full Text Link to Item
-
Bergsma, Derek P., Joseph K. Salama, Deepinder P. Singh, Steven J. Chmura, and Michael T. Milano. “The evolving role of radiotherapy in treatment of oligometastatic NSCLC.” Expert Rev Anticancer Ther 15, no. 12 (2015): 1459–71. https://doi.org/10.1586/14737140.2015.1105745.Full Text Link to Item
-
Salama, Joseph K., and Steven J. Chmura. “Surgery or ablative radiotherapy for breast cancer oligometastases.” Am Soc Clin Oncol Educ Book, 2015, e8-15. https://doi.org/10.14694/EdBook_AM.2015.35.e8.Full Text Link to Item
-
Oh, Daniel S., Bridget Koontz, Stephen J. Freedland, Leah Gerber, Pretesh Patel, Stephen Lewis, David S. Yoo, James Oleson, and Joseph K. Salama. “Statin use is associated with decreased prostate cancer recurrence in men treated with brachytherapy.” World J Urol 33, no. 1 (January 2015): 93–97. https://doi.org/10.1007/s00345-014-1281-x.Full Text Link to Item
-
Salama, Joseph K., and Christopher G. Willett. “Is proton beam therapy better than standard radiation therapy? A paucity of practicality puts photons ahead of protons.” Clin Adv Hematol Oncol 12, no. 12 (December 2014): 861–69.Link to Item
-
Salama, Joseph K., and Steven J. Chmura. “The role of surgery and ablative radiotherapy in oligometastatic breast cancer.” Semin Oncol 41, no. 6 (December 2014): 790–97. https://doi.org/10.1053/j.seminoncol.2014.09.016.Full Text Link to Item
-
Allott, Emma H., Lauren E. Howard, Hai-Jun Song, Katharine N. Sourbeer, Bridget F. Koontz, Joseph K. Salama, and Stephen J. Freedland. “Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy.” Cancer Epidemiol Biomarkers Prev 23, no. 11 (November 2014): 2404–12. https://doi.org/10.1158/1055-9965.EPI-14-0236.Full Text Link to Item
-
Louie, Alexander V., Suresh Senan, Pretesh Patel, Bart S. Ferket, Frank J. Lagerwaard, George B. Rodrigues, Joseph K. Salama, Christopher Kelsey, David A. Palma, and Myriam G. Hunink. “When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis.” Chest 146, no. 4 (October 2014): 1021–28. https://doi.org/10.1378/chest.13-2924.Full Text Link to Item
-
Salama, Joseph K., and Michael T. Milano. “Radical irradiation of extracranial oligometastases.” J Clin Oncol 32, no. 26 (September 10, 2014): 2902–12. https://doi.org/10.1200/JCO.2014.55.9567.Full Text Link to Item
-
Palma, David A., Joseph K. Salama, Simon S. Lo, Suresh Senan, Tom Treasure, Ramaswamy Govindan, and Ralph Weichselbaum. “The oligometastatic state - separating truth from wishful thinking.” Nat Rev Clin Oncol 11, no. 9 (September 2014): 549–57. https://doi.org/10.1038/nrclinonc.2014.96.Full Text Link to Item
-
Salama, Joseph K., Daniel W. Golden, Sue S. Yom, Madhur Kumar Garg, Joshua Lawson, Mark W. McDonald, Harry Quon, et al. “ACR Appropriateness Criteria® thyroid carcinoma.” Oral Oncol 50, no. 6 (June 2014): 577–86. https://doi.org/10.1016/j.oraloncology.2013.12.004.Full Text Link to Item
-
Boyer, Matthew J., Joseph K. Salama, and W Robert Lee. “Palliative radiotherapy for prostate cancer.” Oncology (Williston Park) 28, no. 4 (April 2014): 306–12.Link to Item
-
Kirkpatrick, John P., Christopher R. Kelsey, Manisha Palta, Alvin R. Cabrera, Joseph K. Salama, Pretesh Patel, Bradford A. Perez, Jason Lee, and Fang-Fang Yin. “Stereotactic body radiotherapy: a critical review for nonradiation oncologists.” Cancer 120, no. 7 (April 1, 2014): 942–54. https://doi.org/10.1002/cncr.28515.Full Text Link to Item
-
Louie, A. V., M. G. Hunink, P. Patel, B. S. Ferket, F. J. Lagerwaard, G. B. Rodrigues, J. K. Salama, C. Kelsey, D. A. Palma, and S. Senan. “WHEN IS A PATHOLOGICAL DIAGNOSIS PREFERRED BEFORE STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR STAGE I LUNG CANCER? A DECISION ANALYSIS.” Journal of Thoracic Oncology 9, no. 4 (April 1, 2014): S31–S31.Link to Item
-
Boyer, M. J., J. K. Salama, and W. R. Lee. “Palliative radiotherapy for prostate cancer.” Oncology (Williston Park, N.Y.) 28, no. 4 (January 1, 2014): 306–12.
-
Patel, Pretesh R., John Kirkpatrick, Joseph K. Salama, John Nelson, Gloria Broadwater, Karen Allen, Robert Clough, et al. “Stereotactic ablative body radiotherapy (SABR) for effective palliation of metastases: factors affecting local control.” J Radiosurg Sbrt 3, no. 2 (2014): 123–29.Link to Item
-
Salama, J. K., and C. G.willett. “A paucity of practicality puts photons ahead of protons.” Clinical Advances in Hematology and Oncology 12, no. 12 (January 1, 2014): 861–69.
-
Ridge, John A., Joshua Lawson, Sue S. Yom, Madhur Kumar Garg, Mark W. McDonald, Harry Quon, Nabil Saba, et al. “American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer.” Head Neck 36, no. 1 (January 2014): 3–8. https://doi.org/10.1002/hed.23381.Full Text Link to Item
-
Salama, Joseph K., Herbert Pang, Jeffrey A. Bogart, A William Blackstock, James J. Urbanic, Lydia Hogson, Jeffrey Crawford, and Everett E. Vokes. “Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.” Lung Cancer 82, no. 3 (December 2013): 436–40. https://doi.org/10.1016/j.lungcan.2013.10.001.Full Text Link to Item
-
Ranck, Mark C., Daniel W. Golden, Kimberly S. Corbin, Michael D. Hasselle, Stanley L. Liauw, Walter M. Stadler, Olwen M. Hahn, Ralph R. Weichselbaum, and Joseph Kamel Salama. “Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.” Am J Clin Oncol 36, no. 6 (December 2013): 589–95. https://doi.org/10.1097/COC.0b013e31825d52b2.Full Text Link to Item
-
Cohen, Ezra E. W., Omar Ahmed, Masha Kocherginsky, Galyna Shustakova, Emily Kistner-Griffin, Joseph K. Salama, Volodymyr Yefremenko, and Valentyn Novosad. “Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapy.” Oral Oncol 49, no. 10 (October 2013): 1025–31. https://doi.org/10.1016/j.oraloncology.2013.07.009.Full Text Link to Item
-
Freedland, Stephen J., Leah Gerber, Julia Reid, William Welbourn, Eliso Tikishvili, Jimmy Park, Adib Younus, et al. “Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy.” Int J Radiat Oncol Biol Phys 86, no. 5 (August 1, 2013): 848–53. https://doi.org/10.1016/j.ijrobp.2013.04.043.Full Text Link to Item
-
Salama, Joseph K., Lydia Hodgson, Herbert Pang, James J. Urbanic, A William Blackstock, Steven E. Schild, Jeffrey Crawford, Jeffrey A. Bogart, Everett E. Vokes, and Everett E. Cancer and Leukemia Group B. “A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.” J Thorac Oncol 8, no. 8 (August 2013): 1043–49. https://doi.org/10.1097/JTO.0b013e318293d8a4.Full Text Link to Item
-
Kelsey, Chris R., and Joseph K. Salama. “Stereotactic body radiation therapy for treatment of primary and metastatic pulmonary malignancies.” Surg Oncol Clin N Am 22, no. 3 (July 2013): 463–81. https://doi.org/10.1016/j.soc.2013.02.011.Full Text Link to Item
-
Samuels, Michael A., Shravan Kandula, Tulay Koru-Sengul, Jeffrey A. Bogart, Joseph K. Salama, Paul D. Aridgides, Ajeet Gajra, and Rogerio C. Lilenbaum. “Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium.” Clin Lung Cancer 14, no. 4 (July 2013): 446–51. https://doi.org/10.1016/j.cllc.2013.03.004.Full Text Link to Item
-
Rudra, Sonali, Renuka Malik, Mark C. Ranck, Karl Farrey, Daniel W. Golden, Michael D. Hasselle, Ralph R. Weichselbaum, and Joseph K. Salama. “Stereotactic body radiation therapy for curative treatment of adrenal metastases.” Technol Cancer Res Treat 12, no. 3 (June 2013): 217–24. https://doi.org/10.7785/tcrt.2012.500320.Full Text Link to Item
-
Salama, Joseph K., and Everett E. Vokes. “New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.” J Clin Oncol 31, no. 8 (March 10, 2013): 1029–38. https://doi.org/10.1200/JCO.2012.44.5064.Full Text Link to Item
-
Seiwert, T. Y., T. Darga, D. Haraf, E. A. Blair, K. Stenson, E. E. W. Cohen, J. K. Salama, et al. “A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.” Ann Oncol 24, no. 3 (March 2013): 769–76. https://doi.org/10.1093/annonc/mds523.Full Text Link to Item
-
Garg, Madhur K., John A. Ridge, Sue S. Yom, Mark W. McDonald, Harry Quon, Richard V. Smith, Anamaria Reyna Yeung, et al. “Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer.” Head Neck 35, no. 3 (March 2013): 465–66. https://doi.org/10.1002/hed.23212.Full Text Link to Item
-
Gerber, L., J. E. Reid, W. Welbourn, E. Tikishvili, J. Park, A. Younus, A. Gutin, et al. “Prognostic utility of CCP score in men with prostate cancer after primary external beam radiation therapy.” J Clin Oncol 31, no. 6_suppl (February 20, 2013): 47. https://doi.org/10.1200/jco.2013.31.6_suppl.47.Full Text Link to Item
-
Chmura, Steven J., Joseph K. Salama, and Ralph R. Weichselbaum. “Stereotactic radiotherapy for pulmonary metastases.” Semin Thorac Cardiovasc Surg 25, no. 4 (2013): 292–99. https://doi.org/10.1053/j.semtcvs.2014.01.003.Full Text Link to Item
-
Niibe, Y., J. Y. Chang, H. Onishi, J. Salama, T. Hiraki, and H. Yamashita. “Oligometastases/oligo-recurrence of lung cancer.” Pulmonary Medicine, January 1, 2013. https://doi.org/10.1155/2013/438236.Full Text
-
Corbin, Kimberly S., Mark C. Ranck, Michael D. Hasselle, Daniel W. Golden, Julien Partouche, Tianming Wu, Steven J. Chmura, Ralph R. Weichselbaum, and Joseph K. Salama. “Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease.” Pract Radiat Oncol 3, no. 4 (2013): 316–22. https://doi.org/10.1016/j.prro.2012.08.006.Full Text Link to Item
-
Solanki, Abhishek A., Ralph R. Weichselbaum, Daniel Appelbaum, Karl Farrey, Kamil M. Yenice, Steven J. Chmura, and Joseph K. Salama. “The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study.” Radiat Oncol 7 (December 18, 2012): 216. https://doi.org/10.1186/1748-717X-7-216.Full Text Link to Item
-
Salama, Joseph K., John P. Kirkpatrick, and Fang-Fang Yin. “Stereotactic body radiotherapy treatment of extracranial metastases.” Nat Rev Clin Oncol 9, no. 11 (November 2012): 654–65. https://doi.org/10.1038/nrclinonc.2012.166.Full Text Link to Item
-
Mouw, Kent W., Abhishek A. Solanki, Kerstin M. Stenson, Mary Ellyn Witt, Elizabeth A. Blair, Ezra E. W. Cohen, Everett E. Vokes, Marcy List, Daniel J. Haraf, and Joseph K. Salama. “Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.” Oral Oncol 48, no. 10 (October 2012): 1025–30. https://doi.org/10.1016/j.oraloncology.2012.04.004.Full Text Link to Item
-
Patel, Pretesh R., and Joseph K. Salama. “Reirradiation for recurrent head and neck cancer.” Expert Rev Anticancer Ther 12, no. 9 (September 2012): 1177–89. https://doi.org/10.1586/era.12.97.Full Text Link to Item
-
Stenson, Kerstin M., Ellen Maccracken, Rangesh Kunnavakkam, Ezra E. W Cohen, Louis D. Portugal, Victoria Villaflor, Tanguy Seiwert, et al. “Chemoradiation for patients with large-volume laryngeal cancers.” Head Neck 34, no. 8 (August 2012): 1162–67. https://doi.org/10.1002/hed.21888.Full Text Link to Item
-
Salama, Joseph K., Michael D. Hasselle, Steven J. Chmura, Renuka Malik, Neil Mehta, Kamil M. Yenice, Victoria M. Villaflor, et al. “Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.” Cancer 118, no. 11 (June 1, 2012): 2962–70. https://doi.org/10.1002/cncr.26611.Full Text Link to Item
-
Song, H., J. Salama, D. Yoo, J. Oleson, and Q. Wu. “SU-E-J-23: Prostate Bed Motion Study Using Surgical Clips Based on Daily CBCT.” Med Phys 39, no. 6Part6 (June 2012): 3657. https://doi.org/10.1118/1.4734856.Full Text Link to Item
-
Expert Panel on Radiation Oncology--Head & Neck Cancer:, Jonathan J., Anamaria Reyna Yeung, Madhur Kumar Garg, Joshua Lawson, Mark W. McDonald, Harry Quon, John A. Ridge, et al. “ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil.” Head Neck 34, no. 5 (May 2012): 613–16. https://doi.org/10.1002/hed.21993.Full Text Link to Item
-
Xing, Rosie Hongmei, Yves A. Lussier, Joseph K. Salama, Nikolai N. Khodarev, Yong Huang, Qingbei Zhang, Sajid A. Khan, et al. “Abstract 3405: MicroRNA expression characterizes oligometastasis(es).” Cancer Research 72, no. 8_Supplement (April 15, 2012): 3405–3405. https://doi.org/10.1158/1538-7445.am2012-3405.Full Text
-
Zhang, Qingbei, Xinan Yang, Jikun Shen, Joseph K. Salama, Nikolai Khodarev, Michael D. Hasselle, Yong Huang, et al. “Abstract 1369: Mouse models of clinical oligo- and poly-metastatic progression.” Cancer Research 72, no. 8_Supplement (April 15, 2012): 1369–1369. https://doi.org/10.1158/1538-7445.am2012-1369.Full Text
-
McDonald, M. W., J. Lawson, S. S. Yom, M. K. Garg, H. Quon, J. A. Ridge, N. F. Saba, et al. “American College of Radiology Appropriateness Criteria on retreatment of recurrent head-and-neck cancer after prior definitive radiation.” International Journal of Radiation Oncology Biology Physics 82, no. 4 (March 15, 2012): 1315–16. https://doi.org/10.1016/j.ijrobp.2011.10.041.Full Text
-
Hasselle, Michael D., Daniel J. Haraf, Kyle E. Rusthoven, Daniel W. Golden, Ravi Salgia, Victoria M. Villaflor, Niket Shah, et al. “Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.” J Thorac Oncol 7, no. 2 (February 2012): 376–81. https://doi.org/10.1097/JTO.0b013e31824166a5.Full Text Link to Item
-
Patel, Pretesh R., David S. Yoo, Yuzuru Niibe, James J. Urbanic, and Joseph K. Salama. “A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer.” Pulm Med 2012 (2012): 480961. https://doi.org/10.1155/2012/480961.Full Text Link to Item
-
Shumway, D., K. Corbin, R. Salgia, P. Hoffman, V. Villaflor, R. M. Malik, D. J. Haraf, et al. “Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.” Lung Cancer 74, no. 3 (December 2011): 446–50. https://doi.org/10.1016/j.lungcan.2011.05.003.Full Text Link to Item
-
Salama, Joseph K., Thomas E. Stinchcombe, Lin Gu, Xiaofei Wang, Karen Morano, Jeffrey A. Bogart, Jeffrey C. Crawford, et al. “Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105.” Int J Radiat Oncol Biol Phys 81, no. 4 (November 15, 2011): e269–74. https://doi.org/10.1016/j.ijrobp.2011.01.056.Full Text Link to Item
-
Villaflor, V. M., D. Haraf, J. K. Salama, M. Kocherginsky, A. Langerman, G. Gomez-Abuin, P. Beniwal, et al. “Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.” Ann Oncol 22, no. 11 (November 2011): 2501–7. https://doi.org/10.1093/annonc/mdq785.Full Text Link to Item
-
Choe, Kevin S., Daniel J. Haraf, Abhishek Solanki, Ezra E. W. Cohen, Tanguy Y. Seiwert, Kerstin M. Stenson, Elizabeth A. Blair, et al. “Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.” Cancer 117, no. 20 (October 15, 2011): 4671–78. https://doi.org/10.1002/cncr.26084.Full Text Link to Item
-
Salama, J. K., D. J. Haraf, K. M. Stenson, E. A. Blair, M. E. Witt, R. Williams, R. Kunnavakkam, E. E. W. Cohen, T. Seiwert, and E. E. Vokes. “A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.” Ann Oncol 22, no. 10 (October 2011): 2304–9. https://doi.org/10.1093/annonc/mdq736.Full Text Link to Item
-
Oh, D. S., H. Song, S. Freedland, L. Gerber, P. Patel, S. Lewis, D. Yoo, J. Oleson, and J. K. Salama. “Statin Use and Prostate Cancer Recurrence in Men Treated with Brachytherapy.” International Journal of Radiation Oncology*Biology*Physics 81, no. 2 (October 2011): S12–13. https://doi.org/10.1016/j.ijrobp.2011.06.025.Full Text
-
Pederson, Aaron W., Joseph K. Salama, Mary Ellen Witt, Kerstin M. Stenson, Elizabeth A. Blair, Everett E. Vokes, and Daniel J. Haraf. “Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.” Am J Clin Oncol 34, no. 4 (August 2011): 356–61. https://doi.org/10.1097/COC.0b013e3181e8420b.Full Text Link to Item
-
McDonald, Mark W., Joshua Lawson, Madhur Kumar Garg, Harry Quon, John A. Ridge, Nabil Saba, Joseph K. Salama, et al. “ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer.” Int J Radiat Oncol Biol Phys 80, no. 5 (August 1, 2011): 1292–98. https://doi.org/10.1016/j.ijrobp.2011.02.014.Full Text Link to Item
-
Pederson, Aaron W., Joseph K. Salama, Daniel J. Haraf, Mary Ellen Witt, Kerstin M. Stenson, Louis Portugal, Tanguy Seiwert, et al. “Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.” Head Neck Oncol 3 (July 26, 2011): 31. https://doi.org/10.1186/1758-3284-3-31.Full Text Link to Item
-
Expert Panel on Radiation Oncology-Head and Neck, Jonathan J., Joseph K. Salama, Nabil Saba, Harry Quon, Madhur Kumar Garg, Joshua Lawson, Mark W. McDonald, et al. “ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck.” Oral Oncol 47, no. 7 (July 2011): 554–59. https://doi.org/10.1016/j.oraloncology.2011.05.002.Full Text Link to Item
-
Salama, J. K., L. Hodgson, H. Pang, M. R. Green, J. J. Urbanic, A. W. Blackstock, J. Crawford, J. Bogart, E. E. Vokes, and E. E. CALGB. “Predictors of pulmonary toxicity in limited-stage (LS) small cell lung cancer (SCLC) patients treated with concurrent chemotherapy (CTX) and high-dose (70 Gy) daily radiotherapy (RT): A pooled analysis of three CALGB studies.” J Clin Oncol 29, no. 15_suppl (May 20, 2011): 7078.Link to Item
-
Seiwert, T. Y., D. J. Haraf, E. E. Cohen, E. A. Blair, K. Stenson, J. K. Salama, M. Kocherginsky, et al. “A randomized phase II trial of cetuximab-based induction chemotherapy followed by concurrent cetuximab, 5-FU, hydroxyurea, and hyperfractionated radiation (CetuxFHX), or cetuximab, cisplatin, and accelerated radiation with concomitant boost (CetuxPX) in patients with locoregionally advanced head and neck cancer (HNC).” J Clin Oncol 29, no. 15_suppl (May 20, 2011): 5519.Link to Item
-
Salama, J. K., L. Hodgson, H. Pang, M. R. Green, J. J. Urbanic, A. W. Blackstock, J. Crawford, J. Bogart, and E. E. Vokes. “Predictors of pulmonary toxicity in limited-stage (LS) small cell lung cancer (SCLC) patients treated with concurrent chemotherapy (CTX) and high-dose (70 Gy) daily radiotherapy (RT): A pooled analysis of three CALGB studies.” Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 7078–7078. https://doi.org/10.1200/jco.2011.29.15_suppl.7078.Full Text
-
Lussier, Yves A., H Rosie Xing, Joseph K. Salama, Nikolai N. Khodarev, Yong Huang, Qingbei Zhang, Sajid A. Khan, et al. “MicroRNA expression characterizes oligometastasis(es).” Plos One 6, no. 12 (2011): e28650. https://doi.org/10.1371/journal.pone.0028650.Full Text Link to Item
-
Mouw, Kent W., Daniel J. Haraf, Kerstin M. Stenson, Ezra E. Cohen, Xi Xi, Mary Ellyn Witt, Marcy List, Elizabeth A. Blair, Everett E. Vokes, and Joseph K. Salama. “Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.” Arch Otolaryngol Head Neck Surg 136, no. 12 (December 2010): 1226–34. https://doi.org/10.1001/archoto.2010.218.Full Text Link to Item
-
Choe, Kevin S., Joseph K. Salama, Kerstin M. Stenson, Elizabeth A. Blair, Mary Ellyn Witt, Ezra E. W. Cohen, Daniel J. Haraf, and Everett E. Vokes. “Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.” Radiother Oncol 97, no. 2 (November 2010): 318–21. https://doi.org/10.1016/j.radonc.2010.09.003.Full Text Link to Item
-
Pederson, Aaron W., Daniel J. Haraf, Mary-Ellyn Witt, Kerstin M. Stenson, Everett E. Vokes, Elizabeth A. Blair, and Joseph K. Salama. “Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.” Head Neck 32, no. 11 (November 2010): 1519–27. https://doi.org/10.1002/hed.21360.Full Text Link to Item
-
Cohen, Ezra E. W., Daniel J. Haraf, Rangesh Kunnavakkam, Kerstin M. Stenson, Elizabeth A. Blair, Bruce Brockstein, Eric P. Lester, et al. “Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.” J Clin Oncol 28, no. 20 (July 10, 2010): 3336–43. https://doi.org/10.1200/JCO.2009.27.0397.Full Text Link to Item
-
Devisetty, Kiran, and Joseph K. Salama. “Tumor necrosis and cavitation after stereotactic body radiation therapy.” J Thorac Oncol 5, no. 7 (July 2010): 1100–1102. https://doi.org/10.1097/JTO.0b013e3181d899d7.Full Text Link to Item
-
Pederson, Aaron W., Daniel J. Haraf, Elizabeth A. Blair, Kerstin M. Stenson, Mary-Ellyn Witt, Everett E. Vokes, and Joseph K. Salama. “Chemoreirradiation for recurrent salivary gland malignancies.” Radiother Oncol 95, no. 3 (June 2010): 308–11. https://doi.org/10.1016/j.radonc.2010.03.006.Full Text Link to Item
-
Mell, Loren K., James J. Dignam, Joseph K. Salama, Ezra E. W. Cohen, Blase N. Polite, Virag Dandekar, Amit D. Bhate, et al. “Predictors of competing mortality in advanced head and neck cancer.” J Clin Oncol 28, no. 1 (January 1, 2010): 15–20. https://doi.org/10.1200/JCO.2008.20.9288.Full Text Link to Item
-
Quon, Harry, Sue S. Yom, Madhur Kumar Garg, Joshua Lawson, Mark W. McDonald, John A. Ridge, Nabil Saba, et al. “ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas.” Curr Probl Cancer 34, no. 3 (2010): 175–92. https://doi.org/10.1016/j.currproblcancer.2010.04.004.Full Text Link to Item
-
Stenson, Kerstin M., Rangesh Kunnavakkam, Ezra E. W. Cohen, Louis D. Portugal, Elizabeth Blair, Daniel J. Haraf, Joseph Salama, and Everett E. Vokes. “Chemoradiation for patients with advanced oral cavity cancer.” Laryngoscope 120, no. 1 (January 2010): 93–99. https://doi.org/10.1002/lary.20716.Full Text Link to Item
-
Devisetty, Kiran, Loren K. Mell, Joseph K. Salama, David A. Schomas, Robert C. Miller, Ashesh B. Jani, John C. Roeske, Bulent Aydogan, and Steven J. Chmura. “A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy.” Radiother Oncol 93, no. 2 (November 2009): 298–301. https://doi.org/10.1016/j.radonc.2009.07.006.Full Text Link to Item
-
Salama, Joseph K., Robert I. Haddad, Merril S. Kies, Paul M. Busse, Lei Dong, David M. Brizel, Avraham Eisbruch, Roy B. Tishler, Andy M. Trotti, and Adam S. Garden. “Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.” Int J Radiat Oncol Biol Phys 75, no. 3 (November 1, 2009): 725–33. https://doi.org/10.1016/j.ijrobp.2008.11.059.Full Text Link to Item
-
Langerman, Alexander, Colleen Plein, Everett E. Vokes, Joseph K. Salama, Daniel J. Haraf, Elizabeth A. Blair, and Kerstin M. Stenson. “Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.” Arch Otolaryngol Head Neck Surg 135, no. 11 (November 2009): 1133–36. https://doi.org/10.1001/archoto.2009.154.Full Text Link to Item
-
Jain, A. K., J. K. Salama, K. M. Stenson, E. Blair, E. E. Cohen, M. Witt, D. J. Haraf, and E. E. Vokes. “Correlation of body mass index with toxicity and survival in locoregionally advanced head and neck cancer patients treated with induction chemotherapy and concurrent chemoradiotherapy.” J Clin Oncol 27, no. 15_suppl (May 20, 2009): 6074.Link to Item
-
Choe, Kevin S., and Joseph K. Salama. “Advances in radiotherapy for tumors involving the mediastinum.” Thorac Surg Clin 19, no. 1 (February 2009): 133–41. https://doi.org/10.1016/j.thorsurg.2008.09.010.Full Text Link to Item
-
Cao, Junsheng, John C. Roeske, Steve J. Chmura, Joseph K. Salama, Asal N. Shoushtari, Arthur L. Boyer, and Mary K. Martel. “Calculation and prediction of the effect of respiratory motion on whole breast radiation therapy dose distributions.” Med Dosim 34, no. 2 (2009): 126–32. https://doi.org/10.1016/j.meddos.2008.07.002.Full Text Link to Item
-
Salama, J. K., K. M. Stenson, E. O. Kistner, B. B. Mittal, A. Argiris, M. E. Witt, F. Rosen, et al. “Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.” Ann Oncol 19, no. 10 (October 2008): 1787–94. https://doi.org/10.1093/annonc/mdn364.Full Text Link to Item
-
Salama, Joseph K., Kerstin M. Stenson, Marcy A. List, Loren K. Mell, Ellen Maccracken, Ezra E. Cohen, Elizabeth Blair, Everett E. Vokes, and Daniel J. Haraf. “Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.” Arch Otolaryngol Head Neck Surg 134, no. 10 (October 2008): 1060–65. https://doi.org/10.1001/archotol.134.10.1060.Full Text Link to Item
-
Knab, B. R., J. K. Salama, A. Solanki, K. M. Stenson, E. E. Cohen, M. E. Witt, D. J. Haraf, and E. E. Vokes. “Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.” Ann Oncol 19, no. 9 (September 2008): 1650–54. https://doi.org/10.1093/annonc/mdn173.Full Text Link to Item
-
Macdermed, Dhara M., Ralph R. Weichselbaum, and Joseph K. Salama. “A rationale for the targeted treatment of oligometastases with radiotherapy.” J Surg Oncol 98, no. 3 (September 1, 2008): 202–6. https://doi.org/10.1002/jso.21102.Full Text Link to Item
-
Salama, Joseph K., Steven J. Chmura, Neil Mehta, Kamil M. Yenice, Walter M. Stadler, Everett E. Vokes, Daniel J. Haraf, Samuel Hellman, and Ralph R. Weichselbaum. “An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.” Clin Cancer Res 14, no. 16 (August 15, 2008): 5255–59. https://doi.org/10.1158/1078-0432.CCR-08-0358.Full Text Link to Item
-
Salama, Joseph K., and Everett E. Vokes. “Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.” Semin Oncol 35, no. 3 (June 2008): 251–61. https://doi.org/10.1053/j.seminoncol.2008.03.010.Full Text Link to Item
-
Mell, Loren K., David A. Schomas, Joseph K. Salama, Kiran Devisetty, Bulent Aydogan, Robert C. Miller, Ashesh B. Jani, et al. “Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.” Int J Radiat Oncol Biol Phys 70, no. 5 (April 1, 2008): 1431–37. https://doi.org/10.1016/j.ijrobp.2007.08.074.Full Text Link to Item
-
Salama, J. K., and S. J. Chmura. “In reply.” Journal of Clinical Oncology 26, no. 4 (February 1, 2008): 688–89. https://doi.org/10.1200/JCO.2007.15.0714.Full Text
-
Salama, Joseph K., Loren K. Mell, David A. Schomas, Robert C. Miller, Kiran Devisetty, Ashesh B. Jani, Arno J. Mundt, John C. Roeske, Stanley L. Liauw, and Steven J. Chmura. “Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.” J Clin Oncol 25, no. 29 (October 10, 2007): 4581–86. https://doi.org/10.1200/JCO.2007.12.0170.Full Text Link to Item
-
Salama, Joseph K., Tanguy Y. Seiwert, and Everett E. Vokes. “Chemoradiotherapy for locally advanced head and neck cancer.” J Clin Oncol 25, no. 26 (September 10, 2007): 4118–26. https://doi.org/10.1200/JCO.2007.12.2697.Full Text Link to Item
-
Shaikh, Arif Y., Daniel J. Haraf, Joseph K. Salama, Ravi Salgia, Philip C. Hoffman, Mark K. Ferguson, and Philip P. Connell. “Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers.” Am J Clin Oncol 30, no. 3 (June 2007): 258–63. https://doi.org/10.1097/01.coc.0000258109.83083.78.Full Text Link to Item
-
Seiwert, Tanguy Y., Joseph K. Salama, and Everett E. Vokes. “The chemoradiation paradigm in head and neck cancer.” Nat Clin Pract Oncol 4, no. 3 (March 2007): 156–71. https://doi.org/10.1038/ncponc0750.Full Text Link to Item
-
Seiwert, Tanguy Y., Joseph K. Salama, and Everett E. Vokes. “The concurrent chemoradiation paradigm--general principles.” Nat Clin Pract Oncol 4, no. 2 (February 2007): 86–100. https://doi.org/10.1038/ncponc0714.Full Text Link to Item
-
Zhang, Bin, Natalie A. Bowerman, Joseph K. Salama, Hank Schmidt, Michael T. Spiotto, Andrea Schietinger, Ping Yu, et al. “Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.” Journal of Experimental Medicine 204, no. 1 (January 22, 2007): 49–55. https://doi.org/10.1084/jem.20062056.Full Text Link to Item
-
Zhang, Bin, Natalie A. Bowerman, Joseph K. Salama, Hank Schmidt, Michael T. Spiotto, Andrea Schietinger, Ping Yu, et al. “Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.” J Exp Med 204, no. 1 (January 22, 2007): 49–55. https://doi.org/10.1084/jem.20062056.Full Text Link to Item
-
Cao, J., J. Roeske, S. Schumra, J. Salama, A. Shoushtari, A. Boyer, and M. Martel. “SU‐FF‐T‐11: A Dosimetric Study of the Effect of Respiratory Motion On Whole Breast Radiation Therapy.” Medical Physics 34, no. 6 (January 1, 2007): 2403. https://doi.org/10.1118/1.2760656.Full Text
-
Salama, Joseph K., Arno J. Mundt, John Roeske, and Neil Mehta. “Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies.” Int J Radiat Oncol Biol Phys 65, no. 4 (July 15, 2006): 1170–76. https://doi.org/10.1016/j.ijrobp.2006.02.041.Full Text Link to Item
-
Salama, Joseph K., Everett E. Vokes, Steven J. Chmura, Michael T. Milano, Johnny Kao, Kirsten M. Stenson, Mary Ellyn Witt, and Daniel J. Haraf. “Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.” Int J Radiat Oncol Biol Phys 64, no. 2 (February 1, 2006): 382–91. https://doi.org/10.1016/j.ijrobp.2005.07.005.Full Text Link to Item
-
Milano, Michael T., Everett E. Vokes, Joseph K. Salama, Kerstin M. Stenson, Johnny Kao, Mary-Ellyn Witt, Bharat B. Mittal, Athanassios Argiris, Ralph R. Weichselbaum, and Daniel J. Haraf. “Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.” Int J Radiat Oncol Biol Phys 61, no. 4 (March 15, 2005): 1096–1106. https://doi.org/10.1016/j.ijrobp.2004.08.029.Full Text Link to Item
-
Salama, Joseph K., Ruth Heimann, Fen Lin, Neil Mehta, Steven J. Chmura, Rachana Singh, and Johnny Kao. “Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?” Cancer 103, no. 4 (February 15, 2005): 664–71. https://doi.org/10.1002/cncr.20830.Full Text Link to Item
-
Salama, Joseph K., Daniel J. Haraf, Kerstin Stenson, Michael T. Milano, Mary Ellyn Witt, and Everett E. Vokes. “Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.” Cancer J 11, no. 2 (2005): 140–46. https://doi.org/10.1097/00130404-200503000-00009.Full Text Link to Item
-
Salama, J. K., D. J. Haraf, K. Stenson, and E. E. Vokes. “Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer: Toxicity and outcome results.” J Clin Oncol 22, no. 14_suppl (July 15, 2004): 5561.Link to Item
-
Salama, Joseph K., John C. Roeske, Neil Mehta, and Arno J. Mundt. “Intensity-modulated radiation therapy in gynecologic malignancies.” Curr Treat Options Oncol 5, no. 2 (April 2004): 97–108. https://doi.org/10.1007/s11864-004-0042-2.Full Text Link to Item
-
Hasenburg, Annette, Joseph K. Salama, T John Van, Chad Amosson, J Kam Chiu, and Dirk G. Kieback. “Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer.” Gynecol Oncol 84, no. 2 (February 2002): 321–26. https://doi.org/10.1006/gyno.2001.6528.Full Text Link to Item
-
Salama, J. K., D. J. Haraf, K. Stenson, M. T. Milano, M. E. Witt, and E. E. Vokes. “Phase I Study of Concomitant Chemoradiotherapy with Irinotecan, 5-FU, and Hydroxyurea fot Patients with Advanced and/or Recurrent Head and Neck Cancer.” Cancer Journal 11, no. 2 (December 1, 1998): 140–46.
-
Sugano, N., P. C. Noble, E. Kamaric, J. K. Salama, T. Ochi, and H. S. Tullos. “The morphology of the femur in developmental dysplasia of the hip.” J Bone Joint Surg Br 80, no. 4 (July 1998): 711–19. https://doi.org/10.1302/0301-620x.80b4.8319.Full Text Link to Item
-
Mironova, M., V. Selvamanickam, D. F. Lee, and K. Salama. “TEM studies of dislocations in deformed melt-textured YBa2Cu30x superconductors.” Journal of Materials Research 8, no. 11 (January 1, 1993): 2767–73. https://doi.org/10.1557/JMR.1993.2767.Full Text
-
Morrison, Jay, Rodney Hood, Fang-Fang Yin, Joseph K. Salama, John Kirkpatrick, and Justus Adamson. “Is a single isocenter sufficient for volumetric modulated arc therapy radiosurgery when multiple itracranial metastases are spatially dispersed?” Med Dosim 41, no. 4 (n.d.): 285–89. https://doi.org/10.1016/j.meddos.2016.06.007.Full Text Link to Item
-
-
Book Sections
-
Tanksley, J. P., J. A. Torok, J. K. Salama, and M. Palta. “The multidisciplinary management of early-stage cervical esophageal cancer.” In Esophageal Cancer: Prevention, Diagnosis and Therapy, 221–36, 2019. https://doi.org/10.1007/978-3-030-29832-6_11.Full Text
-
Moghanaki, D., S. Saraiya, and J. K. Salama. “Radiation toxicities and management.” In Modern Thoracic Oncology, 1–3:153–80, 2018.
-
Jacobs, C. D., M. J. Moravan, J. Choe, R. Kahmke, Y. Mowery, and J. K. Salama. “Oral cavity cancer: Diagnosis and treatment.” In Encyclopedia of Cancer, 131–68, 2018. https://doi.org/10.1016/B978-0-12-801238-3.65316-3.Full Text
-
Chmura, S. J., and J. K. Salama. “Stereotactic treatment for oligometastatic breast cancer.” In Short Course Breast Radiotherapy: A Comprehensive Review of Hypofractionation, Partial Breast, and Intra-Operative Irradiation, 467–81, 2015. https://doi.org/10.1007/978-3-319-24388-7_29.Full Text
-
Salama, J. K., M. Palta, and J. A. Torok. “The multidisciplinary management 11 of early stage cervical esophageal cancer.” In Esophageal Cancer: Prevention, Diagnosis and Therapy, 173–85, 2015. https://doi.org/10.1007/978-3-319-20068-2_11.Full Text
-
-
Conference Papers
-
Carpenter, David James, Joseph Kamel Salama, W Robert Lee, and Matthew J. Boyer. “Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: A secondary analysis of the NRG oncology RTOG 0415 randomized clinical trial.” In Journal of Clinical Oncology, 40:243–243. American Society of Clinical Oncology (ASCO), 2022. https://doi.org/10.1200/jco.2022.40.6_suppl.243.Full Text
-
Solanki, Abhishek A., Christopher A. Schroth, Caitlin Authier, Kimberly Carlson, Isla Garraway, Tamara Haegerich, Elizabeth Henry, et al. “Veterans affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligorecurrent prostate cancer (VA STARPORT).” In Journal of Clinical Oncology, 40:TPS203–TPS203. American Society of Clinical Oncology (ASCO), 2022. https://doi.org/10.1200/jco.2022.40.6_suppl.tps203.Full Text
-
Boyer, M. J., J. Janes, J. Bennett, V. Thomas, A. De Hoedt, J. Abran, T. Aboushwareb, J. K. Salama, and S. J. Freedland. “Association between Results from the 17-Gene Genomic Prostate Score Assay and Long-Term Outcomes after External Beam Radiation Therapy in Intermediate- or High-Risk Prostate Cancer Patients, Independent of Race.” In International Journal of Radiation Oncology Biology Physics, 114:E213–E213, 2022.Link to Item
-
Chmura, Steven J., Kathryn A. Winter, Wendy A. Woodward, Virginia F. Borges, Joseph Kamel Salama, Hania A. Al-Hallaq, Martha Matuszak, et al. “NRG-BR002: A phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557).” In Journal of Clinical Oncology, Vol. 40, 2022.Link to Item
-
Fairchild, A., J. K. Salama, D. J. Godfrey, W. Wiggins, B. Ackerson, D. Niedzwiecki, P. Fecci, J. P. Kirkpatrick, and S. R. Floyd. “Early Imaging Characteristics Associated with Development of Future Brain Metastases in Patients Undergoing Stereotactic Radiosurgery.” In International Journal of Radiation Oncology Biology Physics, 114:E51–E51, 2022.Link to Item
-
Fairchild, A., J. K. Salama, W. Wiggins, B. Ackerson, P. Fecci, J. P. Kirkpatrick, S. R. Floyd, and D. J. Godfrey. “A Deep Learning-Based Computer Aided Detection (CAD) System for Difficult-to-Detect Brain Metastases (BM).” In International Journal of Radiation Oncology Biology Physics, 114:S111–12, 2022.Link to Item
-
Freedland, S., M. J. Boyer, J. Janes, J. Bennett, V. M. Thomas, A. M. De Hoedt, J. Abran, T. Aboushwareb, and J. K. Salama. “The Oncotype DX Genomic Prostate Score (R) assay is associated with time to distant metastasis and prostate cancer death after external beam radiation therapy in localized prostate cancer: A retrospective study.” In European Urology, 81:S1413–14, 2022.Link to Item
-
Ritter, T. A., H. H. Chao, M. G. Chang, E. Katsoulakis, L. Padilla, Y. Xiao, H. Kang, et al. “Enhancing Radiation Therapy Plan Quality in a Multi-Site Randomized Clinical Trial with a Benchmark Credentialing Exercise: The VA STARPORT Experience.” In International Journal of Radiation Oncology Biology Physics, 114:S95–96, 2022.Link to Item
-
Solanki, Abhishek A., Christopher A. Schroth, Caitlin Authier, Kimberly Carlson, Isla Garraway, Tamara Haegerich, Elizabeth Henry, et al. “Veterans affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligorecurrent prostate cancer (VA STARPORT).” In Journal of Clinical Oncology, Vol. 40, 2022.Link to Item
-
Shenker, R. F., J. G. Price, C. D. Jacobs, D. Niedzwiecki, T. Oyekunle, H. Song, M. Palta, et al. “Oligometastases Treated With an Elective Simultaneous Integrated Boost Have Reduced Marginal Recurrence Rates.” In International Journal of Radiation Oncology, Biology, Physics, 111:e480, 2021. https://doi.org/10.1016/j.ijrobp.2021.07.1331.Full Text
-
Shulman, R. M., J. K. Wong, E. Handorf, J. K. Salama, D. J. Carpenter, D. J. Godfrey, N. P. Mendenhall, et al. “Dosimetric Predictors of Toxicity in Patients With Early-Stage Prostate Cancer Treated With Moderately Hypofractionated IMRT or PBT: A Multi-Institutional Analysis.” In International Journal of Radiation Oncology, Biology, Physics, 111:e293, 2021. https://doi.org/10.1016/j.ijrobp.2021.07.929.Full Text
-
Sperduto, W., T. Oyekunle, D. Niedzwiecki, B. Czito, C. G. Willett, J. K. Salama, M. Palta, and S. J. Stephens. “Toxicity and Dosimetric Parameters of Ablative Radiation Therapy in the Management of Patients with Child-Pugh B/C Liver Function and Unresectable Hepatocellular Carcinoma (HCC).” In International Journal of Radiation Oncology, Biology, Physics, 111:e78, 2021. https://doi.org/10.1016/j.ijrobp.2021.07.443.Full Text
-
Stephens, S. J., T. Oyekunle, D. Niedzwiecki, C. Eyler, B. Czito, C. G. Willett, J. K. Salama, and M. Palta. “The Role of Hypofractionated Radiation Therapy in the Management of Unresectable Hepatocellular Carcinoma (HCC).” In International Journal of Radiation Oncology, Biology, Physics, 111:e78–79, 2021. https://doi.org/10.1016/j.ijrobp.2021.07.444.Full Text
-
Di Bella, Claire M., Lauren E. Howard, Taofik Oyekunle, Amanda M. De Hoedt, Joseph K. Salama, Stephen J. Freedland, and Emma H. Allott. “DOES ABDOMINAL AND PELVIC ADIPOSE TISSUE DISTRIBUTION IMPACT PROSTATE CANCER-SPECIFIC OUTCOMES AFTER RADIATION THERAPY?” In Journal of Urology, 203:E784–E784. LIPPINCOTT WILLIAMS & WILKINS, 2020.Link to Item
-
Carpenter, D. J., D. Natesan, W. Floyd, D. Niedzwiecki, L. Waters, D. J. Godfrey, MJ Jr Moravan, W. R. Lee, and J. K. Salama. “Long-Term Experience in an Equal Access Health Care System Using Moderately Hypofractionated Radiotherapy for High Risk Prostate Cancer in a Predominately African American Population With Unfavorable Disease.” In International Journal of Radiation Oncology Biology Physics, 108:E417–E417, 2020.Link to Item
-
Natesan, D., D. J. Carpenter, W. Floyd, D. Niedzwiecki, L. Waters, D. J. Godfrey, MJ Jr Moravan, W. R. Lee, and J. K. Salama. “Does Efficacy and Toxicity Differ According to Prostate Volume in Men Treated with Moderately Hypofractionated Radiation Therapy?” In International Journal of Radiation Oncology Biology Physics, 108:E894–95, 2020.Link to Item
-
Price, J. G., D. Niedzwiecki, C. E. Champ, C. R. Kelsey, J. K. Salama, and MJ Jr Moravan. “Effective pain control with very low dose palliative radiotherapy for multiple myeloma patients with painful osseous lesions.” In International Journal of Radiation Oncology Biology Physics, 108:S167–68, 2020.Link to Item
-
Price, J. G., L. Shantzer, C. D. Jacobs, A. Singh, A. Mara, D. Niedzwiecki, J. Clarke, C. R. Kelsey, J. K. Salama, and JA Jr Torok. “Radiation Therapy and Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment.” In International Journal of Radiation Oncology Biology Physics, 108:E149–50, 2020.Link to Item
-
Wong, J. K., N. Vapiwala, E. Handorf, J. J. Paly, R. D. Tendulkar, D. J. Godfrey, D. J. Carpenter, et al. “A Multi-institutional, Propensity Score-Weighted Comparison of Moderately Hypofractionated Photon and Proton Therapy for 1850 Patients with Low or Intermediate Risk Prostate Cancer.” In International Journal of Radiation Oncology Biology Physics, 108:E884–E884, 2020.Link to Item
-
Price, J., L. Shantzer, C. D. Jacobs, D. Niedzwiecki, J. Clarke, C. R. Kelsey, J. K. Salama, and J. A. Torok. “Radiation Therapy Prior to Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment.” In International Journal of Radiation Oncology*Biology*Physics, 105:E527–E527. Elsevier BV, 2019. https://doi.org/10.1016/j.ijrobp.2019.06.2429.Full Text
-
Kozono, David E., Tom Stinchcombe, Joseph Kamel Salama, Jeffrey Bogart, William J. Petty, Michael J. Guarino, Lyudmila Bazhenova, et al. “Veliparib (Vel) in combination with chemoradiotherapy (CRT) of carboplatin/paclitaxel (C/P) plus radiation in patients (pts) with stage III non-small cell lung cancer (NSCLC) (M14-360/AFT-07).” In Journal of Clinical Oncology, Vol. 37. AMER SOC CLINICAL ONCOLOGY, 2019.Link to Item
-
Chmura, Steven J., Kathryn A. Winter, Hania A. Al-Hallaq, Virginia F. Borges, Nora T. Jaskowiak, Martha Matuszak, Michael T. Milano, Joseph Kamel Salama, Wendy A. Woodward, and Julia R. White. “NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer (NCT02364557).” In Journal of Clinical Oncology, 37:TPS1117–TPS1117. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.tps1117.Full Text
-
Chmura, S. J., K. Winter, J. K. Salama, C. G. Robinson, T. M. Pisansky, V. Borges, H. A. Al-Hallaq, et al. “Phase I Trial of Stereotactic Body Radiation Therapy (SBRT) to Multiple Metastatic Sites: A NRG Oncology Study.” In International Journal of Radiation Oncology*Biology*Physics, 102:S68–69. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.06.187.Full Text
-
Godfrey, D. J., F. Vernuccio, S. J. Stephens, J. K. Salama, D. Marin, and M. Palta. “Evaluation of Post-Stereotactic Body Radiation Therapy Response Assessment for Hepatocellular Carcinoma: An Appraisal of RECIST, m-RECIST and WHO Criteria.” In International Journal of Radiation Oncology*Biology*Physics, 102:e53–e53. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.07.473.Full Text
-
Natarajan, B. D., M. A. Cummings, J. Jutzy, C. N. Rushing, K. R. Choudhury, M. J. Moravan, S. J. Chmura, M. T. Milano, J. P. Kirkpatrick, and J. K. Salama. “Patient Factors Predicting Intracranial Progression: Optimizing MRI Surveillance Interval Following Brain Metastases SRS.” In International Journal of Radiation Oncology*Biology*Physics, 102:e308–e308. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.07.965.Full Text
-
Vorren, K., Y. Ge, M. J. Kelley, H. Song, Q. R. J. Wu, and J. K. Salama. “Modeling and Prediction of SIB Prostate IMRT Plans.” In International Journal of Radiation Oncology*Biology*Physics, 102:e541–e541. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.07.1512.Full Text
-
Hong, Julian C., Matthew Boyer, Daphna Spiegel, Christina D. Williams, Betty Caroline Tong, Scott Shofer, Michael James Moravan, Michael J. Kelley, and Joseph Kamel Salama. “Improved survival of small cell lung cancer in the veterans health administration from 2000-2010: Association with increasing utilization of PET staging.” In Journal of Clinical Oncology, 36:e20571–e20571. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e20571.Full Text
-
Luke, Jason J., Steven J. Chmura, Jacob B. Allred, Joseph Kamel Salama, Hania A. Al-Hallaq, Charles Hsu, Sue S. Yom, Mark Kozloff, Pamela N. Munster, and Gary K. Schwartz. “A randomized phase II study of anti-PD1 antibody [MK-3475 (Pembrolizumab)] alone versus anti-PD1 antibody plus stereotactic body radiation therapy in advanced merkel cell carcinoma (Alliance A091605).” In Journal of Clinical Oncology, 36:TPS9599–TPS9599. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.tps9599.Full Text
-
Spiegel, Daphna, Matthew Boyer, Julian C. Hong, Christina D. Williams, Michael J. Kelley, Fatima A. Rangwala, Joseph Kamel Salama, and Manisha Palta. “Role of adjuvant chemotherapy following chemoradiation and surgery for locoregionally advanced rectal cancer: A Veterans Health Administration analysis.” In Journal of Clinical Oncology, 36:741–741. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.4_suppl.741.Full Text
-
Boyer, M. J., C. D. Willaims, M. J. Kelley, and J. K. Salama. “Once Versus Twice Daily Fractionation for Limited Stage SCLC.” In International Journal of Radiation Oncology*Biology*Physics, 99:E442–E442. Elsevier BV, 2017. https://doi.org/10.1016/j.ijrobp.2017.06.1660.Full Text
-
Hong, J. C., D. N. Ayala-Peacock, J. Lee, A. W. Blackstock, P. Okunieff, M. Sung, R. R. Weichselbaum, et al. “Predicting for Long-Term Survival in Oligometastatic Patients Treated With Ablative Radiation Therapy: A Multi-institutional Pooled Analysis.” In International Journal of Radiation Oncology*Biology*Physics, 99:S218–S218. Elsevier BV, 2017. https://doi.org/10.1016/j.ijrobp.2017.06.537.Full Text
-
Spiegel, D., M. J. Boyer, J. C. Hong, C. D. Willaims, M. J. Kelley, J. K. Salama, and M. Palta. “Non-operative Management for Locally Advanced Rectal Cancer in the Veterans Health Administration.” In International Journal of Radiation Oncology*Biology*Physics, 99:S67–68. Elsevier BV, 2017. https://doi.org/10.1016/j.ijrobp.2017.06.165.Full Text
-
Stephens, S. J., Y. A. Abdelazim, S. M. Thomas, J. K. Salama, D. J. Godfrey, C. G. Willett, B. Czito, and M. Palta. “The Impact of Biologically Equivalent Dose on Tumor Control in Unresectable Hepatocellular Carcinoma.” In International Journal of Radiation Oncology*Biology*Physics, 99:E188–89. Elsevier BV, 2017. https://doi.org/10.1016/j.ijrobp.2017.06.1053.Full Text
-
Tandberg, D. J., W. R. Lee, J. K. Salama, and B. F. Koontz. “Toxicity and Biochemical Outcomes of Hypofractionated Intensity Modulated Post-Operative Radiation Therapy for Prostate Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 99:E267–E267. Elsevier BV, 2017. https://doi.org/10.1016/j.ijrobp.2017.06.1241.Full Text
-
Kozono, David E., Joseph Kamel Salama, Tom Stinchcombe, Jeffrey Bogart, William J. Petty, Michael J. Guarino, Lyudmila Bazhenova, et al. “Tolerability of veliparib (V) in combination with carboplatin (C)/paclitaxel (P): Based chemoradiotherapy (CRT) in subjects with stage III non-small cell lung cancer (NSCLC).” In Journal of Clinical Oncology, 35:8546–8546. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.8546.Full Text
-
Spiegel, Daphna, Julian C. Hong, W Robert Lee, and Joseph Kamel Salama. “A nomogram for testosterone recovery following combined androgen deprivation therapy and radiation therapy for prostate cancer.” In Journal of Clinical Oncology, 35:67–67. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.6_suppl.67.Full Text
-
Chmura, S. J., K. A. Winter, J. K. Salama, W. W. Woodward, V. F. Borges, H. Al-Hallaq, M. Martuszak, et al. “Abstract OT1-04-06: NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) &/or surgical ablation for newly oligometastatic breast cancer.” In Cancer Research, Vol. 77. American Association for Cancer Research (AACR), 2017. https://doi.org/10.1158/1538-7445.sabcs16-ot1-04-06.Full Text
-
Birer, S. R., A. C. Olson, J. Adamson, G. J. Kim, J. K. Salama, and J. P. Kirkpatrick. “Hippocampal Dose From Stereotactic Radiosurgery for 4 to 10 Brain Metastases: Risk Factors and Feasibility of Dose Reduction Via Reoptimization.” In International Journal of Radiation Oncology Biology Physics, 96:E608–9, 2016.Link to Item
-
Boyer, M. J., C. Williams, M. J. Kelley, and J. K. Salama. “Survival With Stereotactic Body Radiation Therapy (SBRT) and Conventional Radiation Therapy (CRT) in Stage I Non-Small Cell Lung Cancer Patients in the Veterans Affairs System.” In International Journal of Radiation Oncology Biology Physics, 96:S9–S9, 2016.Link to Item
-
Mowery, Y. M., J. K. Salama, S. Y. Zafar, H. G. Moore, C. G. Willett, B. Czito, M. B. Hopkins, and M. Palta. “Radiation Oncologists' Practice Patterns and Attitudes Regarding Neoadjuvant Short-Course Radiation Therapy for Rectal Cancer in the United States.” In International Journal of Radiation Oncology Biology Physics, 96:S203–S203, 2016.Link to Item
-
Mowery, Y. M., K. Patel, A. C. Olson, M. K. Khan, J. K. Salama, and A. K. Salama. “Toxicity and Survival for Metastatic Melanoma Patients Treated With Anti-PD1 Therapy and Radiation Treatment.” In International Journal of Radiation Oncology Biology Physics, 96:S158–59, 2016.Link to Item
-
Lemons, J. M., S. J. Chmura, J. J. Luke, J. K. Salama, and H. A. Al-Hallaq. “Feasibility of Delivered Radiation Dose Using Cone Beam Computed Tomography as a Secondary Endpoint in a Phase 1 Trial of MOSART Stereotactic Body Radiation Therapy and Pembrolizumab for Metastatic Solid Tumors.” In International Journal of Radiation Oncology Biology Physics, 96:E631–32, 2016.Link to Item
-
Chmura, Steven J., Kathryn A. Winter, Joseph Kamel Salama, Wendy A. Woodward, Virginia F. Borges, Hania A. Al-Hallaq, Martha Matuszak, et al. “NRG BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer.” In Journal of Clinical Oncology, 34:TPS1098–TPS1098. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.tps1098.Full Text
-
Chmura, S. J., K. A. Winter, J. K. Salama, W. A. Woodward, V. F. Borges, H. Al-Hallaq, M. Matuszak, et al. “Abstract OT3-03-04: NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) &/or surgical ablation for newly oligometastatic breast cancer.” In Cancer Research, Vol. 76. American Association for Cancer Research (AACR), 2016. https://doi.org/10.1158/1538-7445.sabcs15-ot3-03-04.Full Text
-
Stanhope, Carl, Zheng Chang, Zhiheng Wang, Fang-Fang Yin, Grace Kim, Joseph K. Salama, John Kirkpatrick, and Justus Adamson. “Physics considerations for single-isocenter, volumetric modulated arc radiosurgery for treatment of multiple intracranial targets.” In Pract Radiat Oncol, 6:207–13, 2016. https://doi.org/10.1016/j.prro.2015.10.010.Full Text Link to Item
-
Al-Hallaq, H. A., S. J. Chmura, J. K. Salama, J. L. Leif, S. McNulty, J. M. Galvin, D. S. Followill, et al. “Benchmark Credentialing Results for the First Multiple Metastases SBRT Protocol: NRG BR001.” In International Journal of Radiation Oncology*Biology*Physics, 93:S85–86. Elsevier BV, 2015. https://doi.org/10.1016/j.ijrobp.2015.07.205.Full Text
-
Olson, A. C., R. Qin, B. Singh, N. Bhavsar, S. Wolf, J. K. Salama, J. P. Kirkpatrick, and A. K. Salama. “Radiosurgery for Brain Metastases in Melanoma Patients Receiving Ipilimumab.” In International Journal of Radiation Oncology*Biology*Physics, 93:E88–E88. Elsevier BV, 2015. https://doi.org/10.1016/j.ijrobp.2015.07.771.Full Text
-
Wong, A. C., S. Pitroda, S. Watson, C. Son, L. C. Das, A. Uppal, G. Oshima, et al. “Long-term Survivors of an SBRT Dose-Escalation Study for Oligometastases: Clinical and Molecular Markers.” In International Journal of Radiation Oncology*Biology*Physics, 93:S64–S64. Elsevier BV, 2015. https://doi.org/10.1016/j.ijrobp.2015.07.152.Full Text
-
Chmura, Steven J., Kathryn A. Winter, Joseph Kamel Salama, Wendy A. Woodward, Virginia F. Borges, Hania A. Al-Hallaq, Martha Matuszak, et al. “NRG BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer.” In Journal of Clinical Oncology, Vol. 33. AMER SOC CLINICAL ONCOLOGY, 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.tps1105.Full Text Link to Item
-
Lee, J., M. T. Milano, J. Kao, S. Chmura, and J. K. Salama. “A Multi-institution Pooled Analysis of Oligometastatic Patients Treated With SBRT.” In International Journal of Radiation Oncology*Biology*Physics, 90:S699–S699. Elsevier BV, 2014. https://doi.org/10.1016/j.ijrobp.2014.05.2050.Full Text
-
Louie, A. V., S. Senan, P. R. Patel, B. Ferket, F. J. Lagerwaard, G. B. Rodrigues, J. K. Salama, C. R. Kelsey, D. A. Palma, and M. Hunink. “When is a Biopsy-Proven Diagnosis Necessary Before Stereotactic Ablative Radiation Therapy for Lung Cancer? A Decision Analysis.” In International Journal of Radiation Oncology*Biology*Physics, 90:S138–39. Elsevier BV, 2014. https://doi.org/10.1016/j.ijrobp.2014.05.597.Full Text
-
Louie, Alexander V., Suresh Senan, Pretesh Patel, Bart S. Ferket, Frank J. Lagerwaard, George Rodrigues, Joseph Kamel Salama, Christopher Ryan Kelsey, David Palma, and Myriam Hunink. “When is a pathologic diagnosis preferred before stereotactic ablative radiotherapy for stage I lung cancer? A decision analysis.” In Journal of Clinical Oncology, 32:7534–7534. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.7534.Full Text
-
Salama, J. K., S. Freedland, L. Gerber, J. Reid, W. Welbourn, A. Gutin, Z. Sangale, M. Brawer, and S. Stone. “Cell Cycle Progression (CCP) Score Significantly Predicts PSA Failure After EBRT.” In International Journal of Radiation Oncology*Biology*Physics, 87:S125–S125. Elsevier BV, 2013. https://doi.org/10.1016/j.ijrobp.2013.06.322.Full Text
-
Freedland, Stephen J., Leah Gerber, Julia E. Reid, William Welbourn, Eliso Tikishvili, Jimmy Park, Adib Younus, et al. “Prognostic utility of CCP score in men with prostate cancer after primary external beam radiation therapy.” In Journal of Clinical Oncology, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013. https://doi.org/10.1200/jco.2013.31.6_suppl.47.Full Text Link to Item
-
Hasselle, M. D., J. K. Salama, K. E. Tye, D. W. Golden, S. L. Liauw, R. R. Weichselbaum, and R. Malik. “Patterns Of Progression Following Hypofractionated Image-guided Radiotherapy (HIGRT) To Abdominal Lymph Nodes In Oligometastatic (OM) Patients.” In International Journal of Radiation Oncology*Biology*Physics, 81:S654–S654. Elsevier BV, 2011. https://doi.org/10.1016/j.ijrobp.2011.06.1924.Full Text
-
Seiwert, T. Y., D. J. Haraf, E. E. Cohen, E. A. Blair, K. Stenson, J. K. Salama, M. Kocherginsky, et al. “A randomized phase II trial of cetuximab-based induction chemotherapy followed by concurrent cetuximab, 5-FU, hydroxyurea, and hyperfractionated radiation (CetuxFHX), or cetuximab, cisplatin, and accelerated radiation with concomitant boost (CetuxPX) in patients with locoregionally advanced head and neck cancer (HNC).” In Journal of Clinical Oncology, 29:5519–5519. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.5519.Full Text
-
Song, H., and J. Salama. “SU‐E‐T‐266: Propagation of Human Error within a Radiation Oncology Department.” In Medical Physics, 38:3548, 2011. https://doi.org/10.1118/1.3612217.Full Text
-
Corbin, K. S., M. C. Ranck, M. Hasselle, D. W. Golden, J. Partouche, T. Wu, R. R. Weichselbaum, and J. K. Salama. “Hypofractionated Image Guided Radiotherapy for Large Volume Oligometastases.” In International Journal of Radiation Oncology*Biology*Physics, 78:S582–83. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.1358.Full Text
-
Farrey, K., M. Sadinski, D. W. Golden, G. Redler, K. M. Yenice, D. J. Haraf, C. A. Pelizzari, J. K. Salama, and H. A. Al-Hallaq. “Cone-Beam CT (CBCT) May be Necessary to Ensure Planned Spinal Cord Doses are not Exceeded in Head and Neck (H&N) Patients Treated with Intensity Modulated Radiotherapy (IMRT).” In International Journal of Radiation Oncology*Biology*Physics, 78:S680–S680. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.1580.Full Text
-
Malik, R., A. W. Pederson, K. S. Choe, M. E. Witt, J. K. Salama, E. E. Cohen, E. A. Blair, K. M. Stenson, E. E. Vokes, and D. J. Haraf. “Impact of Induction Chemotherapy on Treatment Outcomes in Locoregionally Advanced Head and Neck Carcinoma Patients Treated with Concurrent Chemotherapy and Hyperfractionated Radiotherapy.” In International Journal of Radiation Oncology*Biology*Physics, 78:S435–S435. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.1023.Full Text
-
Ranck, M. C., K. S. Corbin, D. W. Golden, S. L. Liauw, R. R. Weichselbaum, and J. K. Salama. “Hypofractionated Image-guided Radiation Therapy in the Treatment of Oligometastatic Renal Cell Carcinoma.” In International Journal of Radiation Oncology*Biology*Physics, 78:S392–S392. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.925.Full Text
-
Yenice, K. M., J. Partouche, A. Cunliffe, K. Farrey, R. R. Weichselbaum, and J. K. Salama. “Analysis of Radiation Pneumonitis (RP) Incidence in a Phase I Stereotactic Body Radiotherapy (SBRT) Dose Escalation Study for Multiple Metastases.” In International Journal of Radiation Oncology*Biology*Physics, 78:S25–S25. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.098.Full Text
-
Hasselle, M. D., K. E. Rusthoven, B. D. Macrie, N. Shah, D. W. Golden, R. R. Weichselbaum, and J. K. Salama. “Hypofractionated radiotherapy for oligometastatic non-small cell lung carcinoma.” In Journal of Clinical Oncology, 28:e18049–e18049. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.e18049.Full Text
-
Iyengar, N. M., J. K. Salama, K. Stenson, D. J. Haraf, E. A. Blair, E. E. Vokes, and E. E. Cohen. “Routine versus clinically indicated post-treatment surveillance in head and neck cancer.” In Journal of Clinical Oncology, 28:5601–5601. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.5601.Full Text
-
Partouche, J., T. Wu, K. Farrey, J. K. Salama, and K. M. Yenice. “Single Segment Non-coplanar Beam Optimization for Gated Lung SBRT Planning and Delivery.” In International Journal of Radiation Oncology*Biology*Physics, 75:S672–73. Elsevier BV, 2009. https://doi.org/10.1016/j.ijrobp.2009.07.1535.Full Text
-
Jain, A. K., J. K. Salama, K. M. Stenson, E. Blair, E. E. Cohen, M. Witt, D. J. Haraf, and E. E. Vokes. “Correlation of body mass index with toxicity and survival in locoregionally advanced head and neck cancer patients treated with induction chemotherapy and concurrent chemoradiotherapy.” In Journal of Clinical Oncology, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.Link to Item
-
Choe, K. S., A. Solanki, D. J. Haraf, E. E. Cohen, T. Y. Seiwert, K. M. Stenson, E. Blair, M. Witt, E. E. Vokes, and J. K. Salama. “Previous Chemoradiotherapy Predicts for Worse Survival in Patients Undergoing Chemo-reirradiation for Recurrent and Second Primary Head and Neck Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 72:S378–S378. Elsevier BV, 2008. https://doi.org/10.1016/j.ijrobp.2008.06.1232.Full Text
-
Mell, L. K., J. J. Dignam, J. K. Salama, E. E. Cohen, B. N. Polite, A. D. Bhate, D. J. Haraf, B. B. Mittal, E. E. Vokes, and R. R. Weichselbaum. “Factors Associated with Non-cancer Mortality in Advanced Head and Neck Cancer: A Competing Risks Analysis.” In International Journal of Radiation Oncology*Biology*Physics, 72:S42–S42. Elsevier BV, 2008. https://doi.org/10.1016/j.ijrobp.2008.06.859.Full Text
-
Solanki, A., K. Stenson, D. Haraf, K. Choe, E. Cohen, T. Seiwert, E. Blair, E. Vokes, and J. K. Salama. “Pathologic Predictors for Outcome in Recurrent and Second Primary Head and Neck Cancer Patients Undergoing Surgery followed by Concurrent Chemo-reirradiation.” In International Journal of Radiation Oncology*Biology*Physics, 72:S402–3. Elsevier BV, 2008. https://doi.org/10.1016/j.ijrobp.2008.06.1288.Full Text
-
Wu, T., K. Farrey, J. K. Salama, and K. M. Yenice. “Monte Carlo Evaluation of Stereotactic Body Radiotherapy (SBRT) Treatment Planning for Lung Tumors.” In International Journal of Radiation Oncology*Biology*Physics, 72:S615–S615. Elsevier BV, 2008. https://doi.org/10.1016/j.ijrobp.2008.06.249.Full Text
-
Mell, L. K., J. J. Dignam, J. K. Salama, D. J. Haraf, E. E. Vokes, and R. R. Weichselbaum. “Does Cetuximab Improve Control of Advanced Head and Neck Cancer? A Second Look at the Randomized Trial by Bonner, et al.” In International Journal of Radiation Oncology*Biology*Physics, 69:S419–S419. Elsevier BV, 2007. https://doi.org/10.1016/j.ijrobp.2007.07.1562.Full Text
-
Devisetty, K., L. K. Mell, J. K. Salama, A. B. Jani, A. J. Mundt, J. Roeske, B. Aydogan, and S. J. Chmura. “2138.” In International Journal of Radiation Oncology*Biology*Physics, 66:S287–88. Elsevier BV, 2006. https://doi.org/10.1016/j.ijrobp.2006.07.542.Full Text
-
Knab, B. R., J. K. Salama, K. M. Stenson, E. E. Cohen, M. A. List, M. E. Witt, A. Dekker, E. E. Vokes, and D. J. Haraf. “24.” In International Journal of Radiation Oncology*Biology*Physics, 66:S14–S14. Elsevier BV, 2006. https://doi.org/10.1016/j.ijrobp.2006.07.048.Full Text
-
Kochanski, J. D., J. K. Salama, L. K. Mell, K. Stenson, E. Cohen, M. List, M. Witt, A. Dekker, E. Vokes, and D. J. Haraf. “2425.” In International Journal of Radiation Oncology*Biology*Physics, 66:S446–S446. Elsevier BV, 2006. https://doi.org/10.1016/j.ijrobp.2006.07.835.Full Text
-
Mell, L. K., J. K. Salama, J. C. Roeske, K. Devisetty, A. B. Jani, A. J. Mundt, and S. J. Chmura. “2121.” In International Journal of Radiation Oncology*Biology*Physics, 66:S277–78. Elsevier BV, 2006. https://doi.org/10.1016/j.ijrobp.2006.07.525.Full Text
-
Salama, J. K., L. K. Mell, K. Devisetty, A. B. Jani, A. J. Mundt, J. C. Roeske, and S. J. Chmura. “2114.” In International Journal of Radiation Oncology*Biology*Physics, 66:S273–74. Elsevier BV, 2006. https://doi.org/10.1016/j.ijrobp.2006.07.518.Full Text
-
Weichselbaum, R. R., J. K. Salama, N. Mehta, K. M. Yenice, M. K. Martel, P. P. Connell, D. J. Haraf, S. J. Chmura, and S. Hellman. “2564.” In International Journal of Radiation Oncology*Biology*Physics, 66:S523–S523. Elsevier BV, 2006. https://doi.org/10.1016/j.ijrobp.2006.07.977.Full Text
-
Salama, J. K., D. J. Haraf, K. Stenson, and E. E. Vokes. “Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer: Toxicity and outcome results.” In Journal of Clinical Oncology, 22:503S-503S. AMER SOC CLINICAL ONCOLOGY, 2004.Link to Item
-
Birer, Samuel R., Adam C. Olson, Justus Adamson, Rodney Hood, Matthew Susen, Grace Kim, Joseph K. Salama, and John P. Kirkpatrick. “Hippocampal dose from stereotactic radiosurgery for 4 to 10 brain metastases: Risk factors, feasibility of dose reduction via re-optimization, and patient outcomes.” In Med Dosim, 42:310–16, n.d. https://doi.org/10.1016/j.meddos.2017.06.007.Full Text Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.